This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.  |
 |
|
| Date | Title | | | 11/20/09 | H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics| MADISON, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Rates of infection by the 2009 H1N1 influenza virus may have peaked in late October, but the pandemic flu virus continues to be a potential source of illness in all age groups, including the elderly, according to a new report by Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services.
In its most recent Quest Diagnostics Health Trends(TM) Report "Testing for H1N1 in America," ... |
|  | | 11/20/09 | Quest Diagnostics Announces Final Tender Offer Results|
MADISON, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (the "Company") (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today the final results for its previously announced cash tender offer (the "Tender Offer") to purchase any and all of its 5.125% Senior Notes due 2010 and any and all of its 7.50% Senior Notes due 2011 (collectively, the "Notes"). Additional terms and conditions of the Tender Offer are set forth in... |
| | | 11/20/09 | New Hair Data Validate Sharp Downward Trend in Cocaine and Methamphetamine Positivity in General U.S. Workforce, According to Quest Diagnostics Drug Testing Index(TM)|
MADISON, N.J., Nov. 20 /PRNewswire-FirstCall/ -- New data released today by Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of employment-related drug testing services, reveal that drug testing of hair specimens from employees and job applicants in the general U.S. workforce has tracked sharp downward trends in cocaine and methamphetamine use from 2005 to the first half of 2009 that mirror similar drops shown by urine testing. Data in the Quest Diagnostics D... |
| | | 11/18/09 | 2009 H1N1 Flu Test From Quest Diagnostics Now CE Marked For International Distribution Under The Simplexa(TM) Brand Name| Simplexa(TM) molecular RT-PCR test runs on the 3M Integrated Cycler; employs RT-PCR technologies comparable to 2009 H1N1 flu test used by World Health Organization
MADISON, N.J., Nov. 18 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that the Simplexa Influenza A H1N1 (2009) test developed by its Focus Diagnostics business has been CE marked and is now available as a test k... |
| | | 11/17/09 | Quest Diagnostics Announces Pricing of Tender Offer for Any and All of Certain of its Outstanding Notes|
MADISON, N.J., Nov. 17 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (the "Company") (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today the determination of the pricing for its previously announced cash tender offer (the "Tender Offer") to purchase any and all of its 5.125% Senior Notes due 2010 (the "2010 Notes") and any and all of its 7.50% Senior Notes due 2011 (the "2011 Notes" and, together with the 2010 Notes, the "Note... |
| | | 11/13/09 | Quest Diagnostics to Speak at the Lazard Capital Markets 6th Annual Healthcare Conference|
MADISON, N.J., Nov. 13 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Lazard Capital Markets 6th Annual Healthcare Conference in New York City. The presentation is scheduled for Tuesday, November 17, 2009 at 10:55 a.m. Eastern Time.
During the conference, the company will reaffirm its 2009 guidance for revenue growth to approximate 3%, operatin... |
| | | 11/12/09 | Quest Diagnostics Commences Cash Tender Offer for Any and All of Certain of its Outstanding Notes|
MADISON, N.J., Nov. 12 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (the "Company") (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it has commenced a cash tender offer (the "Tender Offer") to purchase any and all of its 5.125% Senior Notes due 2010 (the "2010 Notes") and any and all of its 7.50% Senior Notes due 2011 (the "2011 Notes" and, together with the 2010 Notes, the "Notes"). Additional terms and conditions of ... |
| | | 11/12/09 | Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering|
MADISON, N.J., Nov. 12 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (the "Company") (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it intends to offer $750,000,000 in aggregate principal amount in two series of senior notes in a public offering made under a shelf registration statement filed with the Securities and Exchange Commission, subject to market and other conditions. The notes will be fully and unconditionall... |
| | | 11/02/09 | Quest Diagnostics To Speak At The Oppenheimer 20th Annual Healthcare Conference|
MADISON, N.J., Nov. 2 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Oppenheimer 20th Annual Healthcare Conference in New York City. The presentation is scheduled for Wednesday, November 4, 2009 at 11:25 a.m. Eastern Time.
During the conference, the company will reaffirm its 2009 guidance for revenue growth to approximate 3%, operatin... |
| | | 11/02/09 | New ChartMaxx(R) V5.5 with Recovery Audit Contractor (RAC) Manager Helps Hospitals Handle RAC Audit Requests|
CINCINNATI, Nov. 2 /PRNewswire-FirstCall/ -- MedPlus®, the healthcare information technology subsidiary of Quest Diagnostics® Incorporated (NYSE: DGX), today announced the release of ChartMaxx® V5.5, an upgrade to its industry-leading ChartMaxx document management and imaging solution. With the new optional RAC Manager, ChartMaxx V5.5 helps health care providers tie together electronic forms, discrete data, color coded timers and e-mail alerts, dashboard reports, and release of infor... |
| | | 10/27/09 | New Mexico Health Information Collaborative (NMHIC) Appointed as State's Official Health Information Exchange (HIE)|
ALBUQUERQUE, N.M., Oct. 27 /PRNewswire-FirstCall/ -- Maggie Gunter, PhD, president of the New Mexico Health Information Collaborative (NMHIC), announced today that the organization has been appointed as the state's official health information exchange (HIE) by New Mexico Governor Bill Richardson.
NMHIC will create the health information exchange infrastructure to connect New Mexico's health care providers through a contract with its technology partner, MedPlus, the healthcare info... |
| | | 10/26/09 | MedPlus Maintains Top Ranking in KLAS Industry Report|
MADISON, N.J., Oct. 26 /PRNewswire-FirstCall/ -- MedPlus, the healthcare information technology subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), announced today that it has been recognized as the health care industry's number one Document Management & Imaging (DMI) vendor for its ChartMaxx® enterprise-wide electronic patient record system in the KLAS (1) Enterprise DMI: Finding the Right Stepping-Stone to Full EMR report issued on October 2, 2009 (www.KLASresearch.com). Char... |
| | | 10/22/09 | Quest Diagnostics Health Trends (TM) Report on 2009 H1N1 Influenza| Click here for the full report, including charts and tables -
In 2009, the H1N1 influenza A virus emerged as the first influenza pandemic in forty years. As the leading diagnostic testing company in the U.S. - and the only provider of two commercial tests authorized by the FDA for emergency use* - Quest Diagnostics is uniquely positioned to provide insights into the behavior of this new pandemic virus and its impact on Americans.
In our latest Quest Diagnostics Health TrendsTM Report, we ... |
| | | 10/20/09 | Quest Diagnostics Reports Strong Performance in Third Quarter 2009| - Total revenues of $1.9 billion, up 3.9%
- Diluted earnings of $1.02 per share, up 26%
- Cash flow from operations of $374 million, up 14%
- 2009 EPS outlook increased to a range of $3.80 to $3.85
MADISON, N.J., Oct. 20 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the third quarter ended September 30, 2009, income from continuing operations rose to $192 million, or $... |
| | | 10/16/09 | FDA Issues Another Emergency Use Authorization for Commercial H1N1 Flu Test to Quest Diagnostics' Focus Diagnostics|
MADISON, N.J., Oct. 16 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated (NYSE: DGX), for its 2009 H1N1 influenza virus test. With the EUA, Focus Diagnostics is the only company in the U.S. to offer test kits for detecting the pandemic 2009 H1N1 virus that the FDA has authorized for emergency use by CLIA h... |
| | | 10/07/09 | Quest Diagnostics Brings Genetic Testing for Plavix(R) Response to Coronary Stent Patients at Scripps Health| First saliva-based cardiovascular disease test from Quest Diagnostics identifies gene variants implicated in potentially lethal reaction to popular anti-clotting drug
MADISON, N.J., Oct. 7 /PRNewswire/ -- DNA testing for gene variants that can increase the risk of major coronary events in certain patients taking the anti-clotting drug Plavix® (clopidogrel bisulfate) is now being performed by Quest Diagnostics (NYSE: DGX) for Scripps Health patients electing to undergo coronary stent pro... |
| | | 10/06/09 | Quest Diagnostics to Release Third Quarter Financial Results on October 20, 2009|
MADISON, N.J., Oct. 6 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that its third quarter results will be made public on Tuesday, October 20, before the market opens. The company will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. Eastern Time on that day.
The public may access the conference call through a live audio w... |
| | | 10/05/09 | Methodist Hospital Adopts New Technology Solutions to Improve Care for California Patients and Reduce Operating Costs| MedPlus Centergy(R) Clinical Portal and ChartMaxx(R) Enable Streamlined Chart Completion Online
MADISON, N.J., Oct. 5 /PRNewswire-FirstCall/ -- Methodist Hospital of Arcadia, California, has launched an integrated deployment of innovative health care information technology (HIT) solutions designed to help improve the quality of patient care and deliver operational efficiencies. MedPlus®, the health care information technology subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), pro... |
| | | 09/23/09 | Quest Diagnostics Empowers the Nation's Physicians to Immediately Embrace ePrescribing| Company to Enable All Care360(TM) Labs & Meds Users to Use ePrescribing Feature; Invites All U.S. Physicians to Use Care360 ePrescribing Risk Free for Six Months
MADISON, N.J., Sept. 23 /PRNewswire-FirstCall/ -- Quest Diagnostics (NYSE: DGX) today announced plans to make it easy for every physician in the United States to quickly embrace digital healthcare technology with a six-month, risk-free trial of its Care360(TM) ePrescribing service. For physicians currently using its Care360 Labs & ... |
| | | 09/11/09 | U.S. Food and Drug Administration Clears Vermillion's OVA1(TM) Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass|
MADISON, N.J. and FREMONT, Calif., Sept. 11 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) today cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass. OVA1 is the first FDA-cleared laboratory test that can indicate the likelihood of ovarian cancer with high sensitivity prior to biopsy or exploratory surgery, even if radiological test results fail to indicate malig... |
| | | 09/11/09 | Quest Diagnostics To Speak at the Bank of America Merrill Lynch Global Healthcare Conference|
MADISON, N.J., Sept. 11 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Bank of America Merrill Lynch Global Healthcare Conference in London, United Kingdom. The presentation is scheduled for Tuesday, September 15, 2009 at 9:50 a.m. Greenwich Mean Time, 5:50 a.m. Eastern Time.
During the conference, the company will reaffirm its 2009 guidance fo... |
| | | 09/04/09 | Quest Diagnostics Marks Sixth Year on Dow Jones Sustainability Index|
MADISON, N.J., Sept. 4 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that it was again selected to be part of the Dow Jones Sustainability World Indexes and North America Indexes (DJSI World and DJSI North America). The company is in its sixth year on the World Index (since 2004) and in its fifth on the North American Index (since 2005).
According to Sustainabl... |
| | | 08/20/09 | Focus Diagnostics Launches 2009 H1N1 Flu Test Kit to Commercial Laboratories in the U.S.| First test for detecting the new virus to be authorized by FDA for use by CLIA
high-complexity labs during pandemic emergency
CYPRESS, Calif., Aug. 20 /PRNewswire-FirstCall/ -- Focus Diagnostics, the
infectious disease diagnostics business of Quest Diagnostics Incorporated
(NYSE: DGX), today announced that its Influenza A H1N1 (2009) Real Time RT-PCR
test is now available as a test kit for use by "high complexity" clinical
laboratories in the U.S. The test quali... |
| | | 08/12/09 | Quest Diagnostics Declares Quarterly Cash Dividend| MADISON, N.J., Aug. 12 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, today announced that its Board of Directors declared
a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per
share, payable on October 19, 2009, to shareholders of record on October 2,
2009.
About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic testing,
info... |
| | | 07/24/09 | FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business| MADISON, N.J., July 24 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, today announced that the U.S. Food and Drug
Administration (FDA) has granted an emergency use authorization to the
company's Focus Diagnostics business for its test for detecting the 2009 H1N1
influenza virus (the "pandemic flu virus"), a strain of influenza A virus
initially referred to as the swine flu virus.
T... |
| | | 07/21/09 | Quest Diagnostics Reports Strong Performance in Second Quarter 2009| Total revenues of $1.9 billion, up 3.5%;
Diluted earnings of $1.00 per share, up 20%;
2009 EPS outlook increased to between $3.70 and $3.80
MADISON, N.J., July 21 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced that for the second quarter ended June 30,
2009, income from continuing operations rose to $188 million, or $1.00 pe... |
| | | 07/20/09 | Quest Diagnostics MedPlus Subsidiary Enables New York Clinical Information Exchange (NYCLIX) to Share Meaningful Data and Enhance Patient Care| Patient-Based Record Improves Quality, Safety and Efficiency
MADISON, N.J., July 20 /PRNewswire-FirstCall/ -- MedPlus, the healthcare
information technology subsidiary of Quest Diagnostics Incorporated (NYSE:
DGX), today announced that NYCLIX is now sharing key patient data
electronically among ten unaffiliated healthcare organizations across New York
City using the company's Centergy(TM) suite of integrated health information
exchange (HIE) solutions. NYCLIX partner hospital... |
| | | 07/09/09 | Quest Diagnostics To Release Second Quarter Financial Results| MADISON, N.J., July 9 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced today that its second quarter results will
be made public on Tuesday, July 21, before the market opens. The company will
hold its quarterly conference call with investors to discuss the results
beginning at 8:30 a.m. Eastern Time on that day.
The public may access the conference call through a live audio... |
| | | 06/24/09 | Quest Diagnostics Earns Platinum Honor As 'Best Employer For Healthy Lifestyles'| National Business Group on Health Recognizes HealthyQuest Program for
Fifth Consecutive Year
MADISON, N.J., June 24 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced today that the National Business Group on
Health (NBGH) has awarded its 2009 Best Employers for Healthy Lifestyles
Platinum Award to the company for its HealthyQuest employee wellness program.
The Platinum Award... |
| | | 06/22/09 | Quest Diagnostics HemoCue Subsidiary to Add U.S. Hospital Laboratory Connectivity to Its HemoCue 201 DM Point-of-Care Systems| Agreement with Medical Automation Systems, Inc. Will Add RALS(R)-Plus
Module to Company's Hemoglobin and Glucose Handheld Devices
MADISON, N.J., June 22 /PRNewswire-FirstCall/ -- HemoCue Inc., the U.S.
point-of-care testing distribution subsidiary of Quest Diagnostics
Incorporated (NYSE: DGX), today announced that it has signed an agreement with
Medical Automation Systems, Inc. (MAS) for the development of a RALS(R)-Plus
module for the HemoCue 201 DM analyzer whole blood systems fo... |
| | | 06/17/09 | Quest Diagnostics Announces Final Tender Offer Results| MADISON, N.J., June 17 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced today the final results for its previously
announced cash tender offer to purchase up to $200 million total aggregate
principal amount (the "Tender Cap") of its 5.125% Senior Notes due 2010 and
7.50% Senior Notes due 2011 (collectively, the "Notes"). The terms and
conditions of the tender offer are describe... |
| | | 06/15/09 | Quest Diagnostics to Speak at the Jefferies 3rd Annual Healthcare Conference| MADISON, N.J., June 15 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the
Jefferies 3rd Annual Healthcare Conference in New York City on Thursday, June
18, 2009. The Quest Diagnostics presentation is scheduled to begin at 11:45
a.m. Eastern Time.
The presentation will be webcast live during the conference and will be
available to registere... |
| | | 06/12/09 | Quest Diagnostics Announces Pricing of Tender Offer for Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes| MADISON, N.J., June 12 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced today the determination of the pricing for
its previously announced cash tender offer to purchase up to $200 million
total aggregate principal amount (the "Tender Cap") of its 5.125% Senior Notes
due 2010 and 7.50% Senior Notes due 2011 (collectively, the "Notes"). The
terms and conditions of the tender off... |
| | | 06/12/09 | New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance| Faster reporting aids physicians in identifying HIV mutations that can
inhibit effectiveness of newest class of antiretroviral therapy
MADISON, N.J., June 12 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, today announced the availability of a new laboratory
developed test designed to help physicians determine whether a patient with a
history of HIV drug resistance will respond to th... |
| | | 06/08/09 | Study Finds Noninvasive Blood Test for Liver Fibrosis May Alleviate Need for Liver Biopsies for Some Patients with Chronic Hepatitis C| MADISON, N.J., June 8, 2009 /PRNewswire-FirstCall via COMTEX/ -- A study in the June issue of Clinical Gastroenterology and Hepatology, published by Elsevier, demonstrates that the Hepascore(TM) liver fibrosis blood-serum test panel may help physicians more accurately diagnose and stage liver fibrosis in patients with chronic hepatitis C (HCV), potentially alleviating the need for liver biopsy, the standard of care for staging fibrosis, in a particular subset of patients. The Hepascore test pane... |
| | | 06/08/09 | Quest Diagnostics to Speak at the William Blair & Company 29th Annual Growth Stock Conference| MADISON, N.J., June 8 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the
William Blair & Company 29th Annual Growth Stock Conference in Chicago on
Tuesday, June 9, 2009. The Quest Diagnostics presentation is scheduled to
begin at 8:10 a.m. Central Time.
During the conference, the company will reaffirm its 2009 guidance for
revenue growth ... |
| | | 06/04/09 | Health Care Finance to Implement District's First Medicaid 'Patient Data Hub' Using MedPlus Technology| Health Information Exchange for Medicaid Beneficiaries, Powered by MedPlus
Centergy(TM) Solutions, will Connect Physicians, Hospitals and Clinics to
Accelerate Access to Patient Information and Better Health Outcomes
WASHINGTON, and MADISON, N.J., June 4 /PRNewswire-FirstCall/ -- The
Department of Health Care Finance, DHCF, the District's Medicaid agency,
announced the selection of MedPlus, the health information technology
subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), ... |
| | | 06/03/09 | Quest Diagnostics India Recognized as Laureate by the Computerworld Honors Program| Quest4Health.com Lauded in Healthcare Category for 'Visionary Application
of Information Technology to Promote Positive Social and Economic Progress'
MADISON, N.J., June 3 /PRNewswire-FirstCall/ -- Quest Diagnostics (NYSE:
DGX), the world's leading provider of diagnostic testing, information and
services, today announced that its subsidiary Quest Diagnostics India Pvt.
Ltd. has been recognized as a Laureate by the International Data Group's (IDG)
Computerworld Honors Program. The a... |
| | | 06/03/09 | Quest Diagnostics Announces Early Tender Results of Offer to Purchase Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes| MADISON, N.J., June 3 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced today that, as of 5:00 p.m., New York City
time, on June 2, 2009 (the "Early Tender Date"), the following principal
amounts of its 5.125% Senior Notes due 2010 and 7.50% Senior Notes due 2011
(collectively, the "Notes") have been validly tendered and not validly
withdrawn in connection with its previously ann... |
| | | 06/02/09 | Quest Diagnostics HemoCue AB Subsidiary to Add Avie(TM) Hemoglobin A1c to Diabetes Point-of-Care Test Suite| Agreement to Distribute MEC HbA1c Test To Provide Physicians in U.S. and
Europe With Fast, Accurate Near-Patient Test for Diabetes Monitoring
MADISON, N.J., June 2 /PRNewswire-FirstCall/ -- HemoCue AB, an
international company in the field of point-of-care testing and a subsidiary
of Quest Diagnostics Incorporated (NYSE: DGX), today announced that it has
signed an agreement with MEC Dynamics Corp (MEC) for the exclusive
distribution of the Avie(TM) A1c point-of-care test in the Uni... |
| | | 06/01/09 | Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS, NRAS, and BRAF Gene Mutations in Reflex Testing Service| EGFR Pathway Test analyzes in sequential reflex fashion more mutations
potentially inhibiting anti-EGFR therapy response in metastatic colorectal
cancer patients
MADISON, N.J., June 1 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading cancer diagnostics company,
today launched the EGFR Pathway test (KRAS with reflex to NRAS, BRAF), the
first laboratory-developed test from a national commercial reference
laboratory for comprehensively identify... |
| | | 05/28/09 | Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting| MADISON, N.J., May 28 /PRNewswire-FirstCall/ -- Quest Diagnostics
scientists will present results of three studies revealing the effect of
genomic abnormalities on the diagnosis and treatment of chronic myeloid
leukemia (CML) and prostate cancer during the 45th Annual Meeting of the
American Society of Clinical Oncology (ASCO), scheduled for May 29 through
June 2 in Orlando, FL. Quest Diagnostics Incorporated (NYSE: DGX) is the
world's leading provider of diagnostic testing, informatio... |
| | | 05/19/09 | Quest Diagnostics Commences Cash Tender Offer for Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes| MADISON, N.J., May 19 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced today that it has commenced a cash tender
offer to purchase up to $200 million aggregate principal amount (the "Tender
Cap") of its 5.125% Senior Notes due 2010 and 7.50% Senior Notes due 2011
(collectively, the "Notes"). The terms and conditions of the tender offer are
described in the Offer to Purchase date... |
| | | 05/15/09 | Quest Diagnostics to Speak at the Deutsche Bank 34th Annual Healthcare Conference| MADISON, N.J., May 15 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the
Deutsche Bank 34th Annual Healthcare Conference in Boston on Tuesday, May 19,
2009. The Quest Diagnostics presentation is scheduled to begin at 11:30 a.m.
Eastern Time.
During the conference, the company will reaffirm its 2009 guidance for
revenue growth of approxima... |
| | | 05/15/09 | Quest Diagnostics to Connect to Microsoft HealthVault and Empower Patients and Physicians to Share Diagnostic Laboratory Test Results Online| MADISON, N.J., May 15 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX) announced today that it will enable patients and
their physicians to share diagnostic laboratory test results, using Microsoft
HealthVault(TM). The connection will enable physicians who use Quest
Diagnostics' Care360(TM) patient-centric physician portal to securely
transfer, at a patient's request, diagnostic laboratory test results in a
HIPAA-compliant format into the patient's protected account... |
| | | 05/14/09 | Quest Diagnostics Declares Quarterly Cash Dividend| MADISON, N.J., May 14 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, today announced that its Board of Directors declared
a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per
share, payable on July 20, 2009, to shareholders of record on July 6, 2009.
About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic testing,
information ... |
| | | 05/11/09 | Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus| Real-time PCR test validated using clinical specimens confirmed
positive for Influenza A H1N1 Swine-origin flu virus
MADISON, N.J., May 11 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, today announced that its Focus Diagnostics
infectious disease reference laboratory has introduced a laboratory-developed
real-time polymerase chain reaction (PCR) test to aid in identifying Influe... |
| | | 05/08/09 | Quest Diagnostics Announces Annual Shareholders Meeting Webcast| MADISON, N.J., May 8 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, will conduct its annual meeting of shareholders on
Thursday, May 14th at 10:30 am ET.
An audio webcast will be accessible through the Investor Relations section
of the company Web site at www.QuestDiagnostics.com/investor. For those
unable to listen to the live broadcast, a replay will be available on the Web
site... |
| | | 05/07/09 | Quest Diagnostics to Speak at the Bank of America and Merrill Lynch 2009 Healthcare Conference| MADISON, N.J., May 7 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the Bank
of America and Merrill Lynch 2009 Healthcare Conference in New York City on
Tuesday, May 12, 2009. The Quest Diagnostics presentation is scheduled to
begin at 1:20 p.m. Eastern Time.
During the conference, the company will reaffirm its 2009 guidance for
revenue... |
| | | 05/06/09 | Cocaine Use Among U.S. Workers Declines Sharply in 2008, According to Quest Diagnostics Drug Testing Index(TM)| Methamphetamine Use Drops While Amphetamine Use Continues to Rise
Random Drug Testing Programs May Deter Use, Data Show
MADISON, N.J., May 6 /PRNewswire/ -- Cocaine use among U.S. employees and
job applicants in the general U.S. workforce declined sharply in 2008,
according to the annual Quest Diagnostics Drug Testing Index(TM) (DTI), based
on 5.7 million urine drug tests performed last year by Quest Diagnostics
(NYSE: DGX), the nation's leading provider of drug testing se... |
| | | 04/27/09 | Quest Diagnostics Discovers New Genetic Mutations Affecting Cystic Fibrosis Screening| Company's Scientists also Enhance Industry Standards for Quality Screening
in Three Articles Published in The Journal of Molecular Diagnostics
MADISON, N.J., April 27 /PRNewswire-FirstCall/ -- Quest Diagnostics
scientists provide new insights into genetic factors affecting the accuracy
and quality of Cystic Fibrosis (CF) carrier and newborn screening in three
separate articles published in the May 2009 issue of The Journal of Molecular
Diagnostics. Quest Diagnostics Incorporated (N... |
| | | 04/21/09 | Quest Diagnostics Reports Strong Earnings Growth In First Quarter 2009| Diluted earnings per share of $0.89, up 24%
Total revenues of $1.8 billion, up 1.3%
Cash flow from operations of $273 million, up 73%
2009 EPS outlook increased to between $3.65 and $3.75
MADISON, N.J., April 21 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced that for the first quarter ended March 31,
2009, income from continuing operations was $169 mi... |
| | | 04/15/09 | Quest Diagnostics Finalizes Previously Announced Settlement With Government Related to Test Kit Subsidiary Closed in 2006| MADISON, N.J., April 15, 2009 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics
Incorporated (NYSE: DGX) today announced it finalized resolution of the
previously disclosed federal government investigation related to certain test
kits manufactured by NID, a test kit manufacturing subsidiary closed
voluntarily in 2006. Quest Diagnostics cooperated with the government since
its investigation began in 2004.
Quest Diagnostics will pay $262 million to settle the civil investigation.
While... |
| | | 04/13/09 | Quest Diagnostics to Release First Quarter Financial Results| MADISON, N.J., April 13 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced today that its first-quarter results will
be made public on Tuesday, April 21, before the market opens. It will hold
its quarterly conference call with investors to discuss the results beginning
at 8:30 a.m. Eastern Time on that day.
The public may access the conference call through a live audio webcas... |
| | | 04/03/09 | MedPlus Centergy(TM) Suite for Hospitals and HIEs Paves a New, Faster Path to Healthcare Information Technology Benefits| The Choice of Leading Nationwide Health Information Network Contractors
and Health Information Exchanges Connects Physicians to the Nation's Largest
Provider Network
Visit MedPlus at HIMSS Booth 2362 in Chicago, April 5-9
CINCINNATI, April 3 /PRNewswire-FirstCall/ -- MedPlus, the healthcare
information technology subsidiary of Quest Diagnostics Incorporated (NYSE:
DGX), today introduced a suite of clinical portal and data exchange services
for hospitals and health information ... |
| | | 03/31/09 | Quest Diagnostics to Support Walgreens and Take Care Health Systems' Offer of Free Health Services by Providing Certain Free Laboratory Testing| MADISON, N.J., March 31 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, will provide strep and urine cultures and other
select laboratory testing services for free to qualified patients served
through the Take Care Recovery Plan, which is an offer, announced by Walgreens
(NYSE, Nasdaq: WAG) and Take Care Health Systems, to provide free health care
services at Take Care Clinics. The offer... |
| | | 03/17/09 | Quest Diagnostics ClariSure(TM) Postnatal Molecular Test Receives Clinical Laboratory Approval from New York State| Test aiding diagnosis of mental retardation, birth defects, and autism
spectrum and developmental disorders now approved for use on patients in New
York
MADISON, N.J., March 17 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, today announced that its ClariSure(TM)
microarray-based comparative genomic hybridization (aCGH) postnatal test is
now available for testing on patients in th... |
| | | 03/12/09 | Jon R. Cohen, M.D., Named Senior Vice President and Chief Medical Officer at Quest Diagnostics| Former Chief Policy Advisor to New York Governor David A. Paterson is
distinguished vascular surgeon and healthcare policy expert
MADISON, N.J., March 12 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, today announced that Jon R. Cohen, M.D., Senior
Advisor to New York Governor David A. Paterson, will join the company as
Senior Vice President and Chief Medical Officer on March 30, 20... |
| | | 03/09/09 | Quest Diagnostics to Speak at Barclays Capital Global Healthcare Conference| MADISON, N.J., March 9 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the
Barclays Capital Healthcare Conference in Miami on Tuesday, March 10, 2009.
The Quest Diagnostics presentation is scheduled to begin at 9:00 a.m. Eastern
Time.
During the conference, the company will reaffirm its 2009 guidance for
revenue growth of approximately 3%, ... |
| | | 03/03/09 | Quest Diagnostics Again Named to FORTUNE Magazine's 'World's Most Admired Companies' List| Ranks second overall and first for long-term investment and social
responsibility in industry category
MADISON, N.J., March 3 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, has again been named to FORTUNE magazine's list of
the World's Most Admired Companies. Quest Diagnostics ranked second in the
"Health Care" category of "Pharmacy and Other Services." The 2009 ranking is
the seco... |
| | | 02/20/09 | Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis| Study published in New England Journal of Medicine employs Quest
Diagnostics' blood-based leukemia testing
MADISON, N.J., Feb. 20 /PRNewswire-FirstCall/ -- Testing of blood
specimens may detect abnormal white blood cells in patients years before the
chronic form of lymphocytic leukemia (CLL) develops, according to research
published in the current issue of the New England Journal of Medicine. The
finding may lead to a better understanding of cellular changes that
characterize the ... |
| | | 02/11/09 | Quest Diagnostics Declares Quarterly Cash Dividend| MADISON, N.J., Feb 11, 2009 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share payable on April 20, 2009, to shareholders of record on April 6, 2009.
About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic testing, informati... |
| | | 01/26/09 | Quest Diagnostics Reports Growth in Revenue and Earnings for Fourth Quarter 2008 and Provides 2009 Guidance| MADISON, N.J., Jan 26, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- - Diluted earnings per share of $0.87, up 10%
- Total revenues of $1.8 billion, up 1.7%
- Cash flow from operations improved to $363 million
- 2009 EPS expected to be between $3.50 to $3.70 per diluted share
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended December 31, 2008, income from continu... |
| | | 01/26/09 | Quest Diagnostics' Board Authorizes $500 Million in Share Repurchases| MADISON, N.J., Jan. 26 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced that its Board of Directors has authorized
$500 million in share repurchases. The company had approximately 190 million
common shares outstanding as of December 31, 2008.
"This repurchase program demonstrates confidence in our performance and
commitment to increasing shareholder value," said Surya N. M... |
| | | 01/12/09 | Quest Diagnostics to Release Fourth Quarter and Full Year 2008 Financial Results| MADISON, N.J., Jan. 12 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced today that it will report fourth-quarter
and full year 2008 results and provide financial guidance for 2009 on Monday,
January 26, before the market opens. It will hold its quarterly conference
call with investors to discuss the results beginning at 8:30 a.m. ET on that
day.
The public may access the co... |
| | | 12/19/08 | MedPlus® ChartMaxx® Receives 2008 ‘Best in KLAS’ Ranking for Healthcare Document Management and Imaging Software | Healthcare Professionals Rank ChartMaxx Number One
DMI Solution for Fifth Time
Cincinnati, OH – December 19, 2008 – Healthcare professionals have chosen MedPlus’ ChartMaxx® enterprise-wide electronic patient record system as the top healthcare Document Management and Imaging (DMI) software product, according to the 2008 Top 20 Best in KLAS Awards: Software & Professional Services report, an independent ranking based on customer feedback of top healthcare information technology (HIT) vendor... |
| | | 12/18/08 | Quest Diagnostics Declares Quarterly Cash Dividend| MADISON, N.J., Dec. 18 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, today announced that its Board of Directors declared
a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per
share, payable on January 26, 2009, to shareholders of record on January 9,
2009.
About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic testing,
info... |
| | | 12/02/08 | Quest Diagnostics to Speak at the 20th Annual Piper Jaffray Healthcare Conference| MADISON, N.J., Dec. 2 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the Piper
Jaffray Healthcare Conference in New York City today, December 2, 2008. The
Quest Diagnostics presentation is scheduled to begin at 4:00 p.m. Eastern
Time.
During the conference, the company will reaffirm its 2008 guidance for
revenue growth of greater than 8%,... |
| | | 11/17/08 | Quest Diagnostics' Laboratory in India Accredited by Two Leading Laboratory Accrediting Organizations| - Less than one tenth of one percent of labs in India are CAP and NABL
accredited
- Quest Diagnostics' laboratory also becomes one of only five labs in India
to achieve NGSP certification for Hemoglobin A1c testing for diabetes
MADISON, N.J. and GURGAON, India, Nov. 17 /PRNewswire-FirstCall/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the world's leading provider of
diagnostic testing, information and services, today announced that it... |
| | | 11/10/08 | Quest Diagnostics to Speak at the 2008 Credit Suisse Healthcare Conference| MADISON, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the
Credit Suisse Healthcare Conference on Wednesday, November 12, 2008. The
Quest Diagnostics presentation is scheduled to begin at 10:00 a.m. Eastern
Time.
During the conference, the company will reaffirm its 2008 guidance for
revenue growth of greater than 8%, operat... |
| | | 10/25/08 | Rotavirus Infections Decline More than 70 Percent in Children in U.S.| Quest Diagnostics Health Trends(TM) Report shows declines vary widely by
state
MADISON, N.J., Oct. 25 /PRNewswire-FirstCall/ -- The largest study of
rotavirus laboratory data developed since an oral rotavirus vaccine was
introduced in the U.S. in early 2006 shows that cases of rotavirus infection
have decreased significantly, suggesting the vaccine is preventing infection
in infants and young children. The latest Quest Diagnostics Health Trends(TM)
Report also provides evidence fo... |
| | | 10/21/08 | Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008|
Total revenues of $1.8 billion, up 3.4%
Adjusted diluted earnings per share of $0.86, up 12%
Cash flow from operations improved to $329 million
2008 adjusted EPS guidance increased to $3.17 - $3.22 per diluted share
Agreement in principle reached regarding previously disclosed
NID-related matter
MADISON, N.J., Oct. 21 /PRNewswire-FirstCall/ -- , 2008-- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, informa... |
| | | 10/08/08 | Quest Diagnostics to Release Third Quarter 2008 Financial Results| MADISON, N.J., Oct. 8 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that its third-quarter 2008 results will be made public on Tuesday, October 21, before the market opens, and that it will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. ET on that day.
The public may access the conference call through a live audio webcast availa... |
| | | 09/23/08 | Quest Diagnostics to Speak at the 2008 UBS Global Life Sciences Conference| MADISON, N.J., Sept. 23 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the 2008
UBS Global Life Sciences Conference on Wednesday, September 24, 2008. The
Quest Diagnostics presentation is scheduled to begin at 8:00 a.m. Eastern
Time.
The presentation will be webcast live during the conference and will be
available to registered investors ... |
| | | 09/10/08 | Quest Diagnostics Again Named to Dow Jones Sustainability World and North American Indexes| 2008 marks fifth year on World Index
MADISON, N.J., Sept. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, today announced that it was again selected to be
part of the Dow Jones Sustainability (DJSI) World and North American Indexes.
The company is in its fifth year on the World Index, first added in 2004, and
has appeared on the North American Index since 2005.
... |
| | | 08/05/08 | Quest Diagnostics Declares Quarterly Cash Dividend| MADISON, N.J., Aug. 5 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, today announced that its Board of Directors declared
a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per
share, payable on October 20, 2008, to shareholders of record on October 3,
2008.
About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic testing,
infor... |
| | | 07/22/08 | Quest Diagnostics Reports Strong Revenue and Earnings Growth in Second Quarter 2008|
- Total revenues of $1.8 billion, up 12%;
- Diluted earnings of $0.83 per share, up 14%;
- Cash flow improved to $213 million;
- 2008 EPS guidance midpoint increased, new range $3.10 to $3.20 per
diluted share.
MADISON, N.J., July 22 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced that for the second quarter ended June 30,
2008, income from con... |
| | | 07/10/08 | Quest Diagnostics to Release Second Quarter 2008 Financial Results| MADISON, N.J., July 10 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced today that its second-quarter 2008 results
will be made public on Tuesday, July 22, before the market opens, and that it
will hold its quarterly conference call with investors to discuss the results
beginning at 8:30 a.m. ET on that day.
The public may access the conference call through a live audio webc... |
| | | 06/23/08 | Quest Diagnostics to Speak at the Jefferies 2nd Annual Healthcare Conference| MADISON, N.J., June 23 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the
Jefferies Healthcare Conference on Tuesday, June 24, 2008. The Quest
Diagnostics presentation is scheduled to begin at 9:00a.m. Eastern Time.
The presentation will be webcast live during the conference and will be
available to registered investors on the following si... |
| | | 06/20/08 | Quest Diagnostics to Provide Diagnostic Testing Services for the Women of Ireland through Ireland's First Nationwide Cervical-Cancer Screening Program| MADISON, N.J., June 20 /PRNewswire-FirstCall/ -- Women in Ireland will
soon be able to take advantage of diagnostic testing services provided by
Quest Diagnostics Incorporated (NYSE: DGX), the world's leader in
cervical-cancer screening services. Through a contract with the Irish National
Cancer Screening Service (NCSS), Quest Diagnostics will provide
quality-assured screening services intended to improve medical outcomes and
reduce anxiety wait time for women ages 25 to 60 who partici... |
| | | 06/18/08 | HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker| MADISON, N.J., June 18 /PRNewswire-FirstCall/ -- HemoCue(R) AB, a global
point-of-care diagnostic test manufacturer and wholly owned subsidiary of
Quest Diagnostics Incorporated (NYSE: DGX), today announced that its HemoCue
Albumin 201 System is the first quantitative point-of-care test for screening
for, diagnosing and monitoring microalbuminuria to be granted a CLIA waiver by
the U.S. Food and Drug Administration (FDA). With the FDA CLIA waiver,
non-laboratory trained physicians and... |
| | | 06/03/08 | Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds| MADISON, N.J., June 3 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX) today announced results of a study that demonstrates
that a novel diagnostic testing technique it has developed is the first to
provide direct, accurate and reproducible physical measurement of both the
size and concentration of a broad range of lipoproteins in blood plasma.
Results of the study were published in the May 29, 2008, online edition of
Clinical Chemistry.
"Our data suggest that ... |
| | | 05/21/08 | Quest Diagnostics Declares Quarterly Cash Dividend| MADISON, N.J., May 21 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, today announced that its Board of Directors declared
a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per
share, payable on July 18, 2008, to shareholders of record on July 3, 2008.
About Quest Diagnostics
Quest Diagnostics is the leading provider of diagnostic testing,
information and ser... |
| | | 05/20/08 | Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds| SAN DIEGO, May 20 /PRNewswire-FirstCall/ -- An interim analysis of a study
presented today at the 39th Annual Digestive Disease Week (DDW) Conference
found that, among patients at increased risk for colorectal cancer who
completed an annual fecal immunochemical (FIT) test, detection of cancerous
lesions occurred an average of 26.5 months earlier than would have occurred
during the three- or five-year study-required colonoscopy. Detection of
precancerous lesions in this group occurred 1... |
| | | 05/19/08 | Quest Diagnostics and Google Empower Patients and Physicians to Share Diagnostic Test Results Online With Launch of Google Health| MADISON, N.J., May 19 /PRNewswire-FirstCall/ -- Patients and physicians
have a new way to share diagnostic laboratory data online, thanks to Quest
Diagnostics and Google Health, a product launched today by Google. More than
100,000 physicians in the U.S. who use Quest Diagnostics' family of
Care360(TM) connectivity products will be able to securely provide diagnostic
data with a brief explanation of test results to a patient's Google Health
Account, where a patient can maintain medica... |
| | | 05/13/08 | Quest Diagnostics Is Named 'Best Employer For Healthy Lifestyles'| Company's "Biggest Loser" Bill Germanakos to Deliver NBGH Keynote Address
MADISON, N.J., May 13 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the leading provider of diagnostic testing,
information and services, announced today that the National Business Group on
Health (NBGH), an association of more than 300 large U.S. employers, has
presented its 2008 Best Employers for Healthy Lifestyles Gold Award to the
company for its HealthyQuest employee wellness progr... |
| | | 05/12/08 | Quest Diagnostics Announces Annual Shareholder's Meeting Webcast| MADISON, N.J., May 12 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the leading provider of diagnostic testing,
information and services, will conduct its annual meeting of shareholders on
Friday, May 16th at 10:30 am ET.
An audio webcast will be accessible through the Investor Relations section
of the company Web site at www.questdiagnostics.com/investor . For those
unable to listen to the live broadcast, a replay will be available on the Web
site beginni... |
| | | 05/08/08 | Enterix Inc. Launches Its Point-of-Care Test for Colorectal Cancer Screening| - New test provides laboratory-quality results in physician's office -
MADISON, N.J., May 8 /PRNewswire-FirstCall/ -- Enterix Inc., a
wholly-owned subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today
announced the availability of the InSure(R) Quik F I T(TM) fecal
immunochemical test, a point-of-care version of the company's lab-based
InSure(R) FIT(TM) test, that provides physicians with the sensitivity and
specificity of the laboratory-based InSure FIT test.
The av... |
| | | 04/21/08 | Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008| - 2008 Outlook Reaffirmed -
MADISON, N.J., April 21 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that for the first quarter ended March 31,
2008, income from continuing operations was $141 million, or $0.72 per diluted
share, compared to $108 million, or $0.55 per diluted share, in the first
quarter of 2007. Included in the results for the first qu... |
| | | 04/07/08 | Quest Diagnostics to Release First Quarter 2008 Financial Results and Conduct Quarterly Investor Conference Call| MADISON, N.J., April 7, 2008 /PRNewswire/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that it will make public its
first-quarter 2008 results on Monday, April 21, before the market opens, and
that it will conduct it's first quarter investor conference call at 8:30 a.m.
ET on that day.
The public may access the conference call through a live audio webcast
available on Quest Diagnostics... |
| | | 03/31/08 | Quest Diagnostics Campaign Challenges Colorectal Cancer Screening Status Quo| 'Do You Have the Guts?' aims to reach five million in five yearsMADISON, N.J., March 31, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing
information and services, today announced the launch of a novel campaign
designed to help increase compliance with take-home colorectal screening
tests. Titled "It's Time to Challenge Colon Cancer: Do You Have the Guts?,"
the campaign aims to break down ... |
| | | 03/14/08 | Quest Diagnostics to Speak at Lehman Brothers 11th Annual Global Healthcare Conference| MADISON, N.J., March 14 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the
Lehman Brothers Eleventh Annual Global Healthcare Conference on Wednesday,
March 19, 2008, at The Loews Miami Beach Hotel, Miami, Florida. The Quest
Diagnostics presentation is scheduled to begin at 9:00 a.m. Eastern Time.
The presentation will be webcast live duri... |
| | | 03/14/08 | Quest Diagnostics to Speak at Cowen and Company 28th Annual Health Care Conference| MADISON, N.J., March 14 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the Cowen
and Company Twenty Eighth Annual Health Care Conference on Tuesday, March 18,
2008, at the Marriott Copley Place, Boston, Massachusetts. The Quest
Diagnostics presentation is scheduled to begin at 8:45 a.m. Eastern Time.
The presentation will be webcast live ... |
| | | 03/12/08 | Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds| MADISON, N.J., March 12 /PRNewswire-FirstCall/ -- Diabetes and
hypertension are the two leading risk factors for chronic kidney disease
(CKD), responsible for up to two-thirds of cases. Yet a new study that will be
presented at a National Kidney Foundation Spring Clinical Meeting next month
indicates there is wide discrepancy in diagnostic testing for kidney disease
among patients with these conditions, with patients with high blood pressure
(hypertension) tested at half the rate as th... |
| | | 03/12/08 | Use of Methamphetamine Among U.S. Workers and Job Applicants Drops 22 Percent in 2007 and Cocaine Use Slows Dramatically, Reports Quest Diagnostics| MADISON, N.J., March 12 /PRNewswire-FirstCall/ -- The percentage of
positive tests for methamphetamine among U.S. job applicants and workers in
the general U.S. workforce dropped more than 22 percent between 2006 and 2007.
These findings, from the Quest Diagnostics Drug Testing Index(R), reflect the
reversal of an upward trend in use of the drug by more than 73 percent from
2002 to 2004. These data were released today by Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading... |
| | | 03/05/08 | Quest Diagnostics Named to FORTUNE Magazine's America's Most Admired Companies List| Only diagnostic testing company in rankingMADISON, N.J., March 5, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics
Incorporated (NYSE: DGX) today announced that it has been selected by FORTUNE
magazine to the 2008 list of America's Most Admired Companies. Quest
Diagnostics was ranked third among four companies in the "Health Care"
category of "pharmacy and other services." 2008 marks the first year the
company has been named to the list.
"Our ranking as one of the m... |
| | | 02/28/08 | Quest Diagnostics to Collaborate with Google on New Health Offering| Partnership will provide patients electronic access to their diagnostic
laboratory data
MADISON, N.J., Feb. 28 /PRNewswire-FirstCall/ -- Patients nationwide may
soon have easy and secure access to their own medical diagnostic laboratory
records as a result of a new collaboration between Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, and Google, the world's leading Internet sear... |
| | | 02/25/08 | MedPlus Technology Driving Three New York Health Information Exchanges| Clinical Portal & Data Exchange Engine Implementations Begin for HEAL 1 Grant
Recipients
CINCINNATI, Feb. 25 /PRNewswire/ -- MedPlus(R), the healthcare information
technology subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), announced
today that it has begun installations of its Clinical Portal & Data Exchange
Engine for three health information exchanges (HIE) qualified for HEAL NY
(Healthcare Efficiency and Affordability Law for New Yorkers) ... |
| | | 02/21/08 | Quest Diagnostics Reports Fourth Quarter and Full Year Results| Company Provides 2008 Guidance
MADISON, N.J., Feb. 21 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that for the fourth quarter ended December
31, 2007, income from continuing operations was $154 million, or $0.79 per
diluted share, compared to $151 million, or $0.77 per diluted share, in the
fourth quarter of 2006. The fourth quarter of 2007 include... |
| | | 02/20/08 | Birla Sun Life Insurance Names Quest Diagnostics its Exclusive Provider of Health Assessment Services in India| MADISON, N.J., Feb. 20 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE:DGX), the leading provider of diagnostic testing,
information and services, today announced that its wholly-owned subsidiary
Quest Diagnostics India Pvt. Ltd. has entered into a long-term agreement to
provide health assessment services, including diagnostic laboratory testing,
for Birla Sun Life Insurance Company Limited (Birla Sun Life), a joint venture
between The Aditya Birla Group, one of the larg... |
| | | 02/19/08 | Quest Diagnostics to Develop Blood Test to Aid in the Detection of Colorectal Cancer| Company Licenses Septin-9 DNA Methylation Biomarker from Epigenomics
MADISON, N.J., Feb. 19 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the leading provider of diagnostic testing,
information and services, today announced that it has licensed rights to uses
of the Septin 9 DNA methylation biomarker from Epigenomics AG (Frankfurt,
Prime Standard: ECX), a cancer molecular diagnostics company, to develop a
molecular-based laboratory test that can help physic... |
| | | 02/15/08 | Focus Diagnostics Launches Laboratory Test for Chikungunya Virus| First Laboratory Developed Test in the U.S. for Detecting the Mosquito-Borne Infectious Disease
CYPRESS, Calif., Feb 15, 2008 /PRNewswire via COMTEX News Network/ -- Focus Diagnostics, Inc., the
infectious disease diagnostics company of Quest Diagnostics (NYSE: DGX), today
announced the first laboratory developed test in the U.S. for detecting the
mosquito-borne chikungunya virus. Commercial availability of the molecular
polymerase chain reaction (PCR) test will enable physicians in the U... |
| | | 02/14/08 | Quest Diagnostics Declares Quarterly Cash Dividend| MADISON, N.J., Feb. 14 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, today announced that its Board of Directors declared
a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per
share, payable on April 18, 2008, to shareholders of record on April 4, 2008.
About Quest Diagnostics
Quest Diagnostics is the leading provider of diagnostic testing,
information and ... |
| | | 01/29/08 | Quest Diagnostics to Speak at Wachovia Securities 2008 Healthcare Conference| MADISON, N.J., Jan. 29 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the
Wachovia Securities 2008 Healthcare Conference on Wednesday, January 30, 2008,
at the Langham Hotel, Boston, Massachusetts. The Quest Diagnostics
presentation is scheduled to begin at 8:00 a.m. Eastern Time.
During the conference, the company will reaffirm its 2007 ... |
| | | 01/17/08 | Quest Diagnostics Sets New Date to Report Fourth Quarter and Full Year 2007 Results| Reaffirms Previous Guidance for 2007
MADISON, N.J., Jan. 17 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it will report results for the fourth
quarter and year ended December 31, 2007 and provide financial guidance for
2008 on February 21, 2008, instead of the previously scheduled date of January
29.
The company is rescheduling its report of f... |
| | | 01/11/08 | MedPlus to Implement Clinical Portal and Information Exchange for the Brooklyn Health Information Exchange| MADISON, N.J., Jan. 11 /PRNewswire/ -- MedPlus, the healthcare information
technology subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today
announced that it has been awarded a contract to implement a clinical portal
and information exchange for the Brooklyn Health Information Exchange (BHIX).
Organized by Maimonides Medical Center and other healthcare organizations in
New York, the BHIX is a not-for-profit corporation that will offer health
information exchange services in B... |
| | | 01/07/08 | Quest Diagnostics to Speak at the 26th Annual JPMorgan Healthcare Conference| MADISON, N.J., Jan 07, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the 26th
Annual JPMorgan Healthcare Conference on Tuesday, January 8, 2008, at the
Westin St. Francis in San Francisco, California. The Quest Diagnostics
presentation is scheduled to begin at 11:00 a.m. Eastern Time.
The presentation will be webcast ... |
| | | 12/18/07 | Quest Diagnostics Declares Quarterly Cash Dividend| MADISON, N.J., Dec 18, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, today announced that its Board of Directors declared
a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per
share, payable on January 23, 2008, to shareholders of record on January 9,
2008.
About Quest Diagnostics
Quest Diagnostics is the leading provider of diagnostic te... |
| | | 11/26/07 | Quest Diagnostics to Speak at the Merrill Lynch Health Services Investor Conference| MADISON, N.J., Nov. 26 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the
Merrill Lynch Health Services Investor Conference at the Merrill Lynch
Headquarters in New York City on Tuesday, November 27, 2007. The Quest
Diagnostics presentation is scheduled to begin at 10:15 a.m. Eastern Time.
During the conference, the company will reiterate ... |
| | | 11/06/07 | Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease| MADISON, N.J., Nov. 6 /PRNewswire-FirstCall/ -- The majority of people
with diabetes and/or high blood pressure -- the two leading causes of chronic
kidney disease (CKD) -- are not receiving recommended tests to identify this
disease early, when medical treatment can slow or halt disease progression,
according to the latest Quest Diagnostics Health Trends(TM) Report. In
addition, the report's findings suggest that patients with early-stage CKD are
not being well managed for contributin... |
| | | 11/01/07 | Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance| First step for performing important diagnostics in physician offices
MADISON, N.J., Nov. 1 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, today announced that its HemoCue and Focus
Diagnostics subsidiaries have received FDA 510(k) clearance for two new point
of care tests. The HemoCue(R) White Blood Cell (WBC) Analyzer is a whole-blood
test performed on finger-stick samples that a... |
| | | 10/26/07 | Quest Diagnostics Licenses Technology Underlying SensiTrop(TM) HIV Co-Receptor Tropism Test from Pathway Diagnostics| -First national diagnostic testing company to license proprietary technology-
MADISON, N.J., Oct. 26 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that it has entered into a non-
exclusive license agreement for the heteroduplex tracking technology
underlying Pathway Diagnostics' SensiTrop(TM) HIV co-receptor tropism test.
Tropism refers to the way a virus targets host ... |
| | | 10/24/07 | Quest Diagnostics Reports Third Quarter Results| - Operating performance improvement continues -
MADISON, N.J., Oct. 24 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that for the third quarter ended September
30, 2007, income from continuing operations was $150 million, or $0.77 per
diluted share, compared to $164 million, or $0.82 per diluted share in the
third quarter of 2006. The third quarter of 2007 inc... |
| | | 10/09/07 | Quest Diagnostics Joins National ePrescribing Patient Safety Initiative (NEPSI)| Collaboration Expected to Drive Physician Adoption of Patient-Safety
Technology
eRx NOW(TM) Functionality Expanded to Include Quest Diagnostics Care360(TM)
Physician Portal Lab Order and Results Capabilities
LYNDHURST, N.J. and CHICAGO, Oct. 9 /PRNewswire-FirstCall/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services and a leading developer of
healthcare IT... |
| | | 09/21/07 | Quest Diagnostics to Speak at the 2007 UBS Global Life Sciences Conference| LYNDHURST, N.J., Sept. 21 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the 2007
UBS Global Life Sciences Conference in New York City on Monday, September 24,
2007. The Quest Diagnostics presentation is scheduled to begin at 4:30 p.m.
Eastern Time.
The presentation will be webcast live during the conference and will be
available to regis... |
| | | 09/10/07 | Quest Diagnostics Again Selected as Part of Dow Jones Sustainability World and North American Indexes| LYNDHURST, N.J., Sept. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, today announced that it was again selected to be
part of the Dow Jones Sustainability (DJSI) World and North American Indexes.
The company was first added to the World Index in 2004 and the North American
Index in 2005.
According to DJSI, companies were identified as "sustainability leaders"
and ranked accord... |
| | | 09/10/07 | Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference| LYNDHURST, N.J., Sept. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the Bear
Stearns Healthcare Conference in New York City on Tuesday, September 11, 2007.
The Quest Diagnostics presentation is scheduled to begin at 9:30 a.m. Eastern
Time.
During the conference, the company will reiterate its 2007 guidance for
revenues of between $... |
| | | 08/30/07 | Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children| First commercial test available nationally
LYNDHURST, N.J., Aug. 30 /PRNewswire-FirstCall/ -- A molecular diagnostic
test that detects chromosome abnormalities associated with 85 developmental
disorders affecting children now is commercially available from a national
diagnostic testing company, affording testing and reimbursement by leading
health plans across the U.S. Quest Diagnostics Incorporated (NYSE: DGX), the
nation's leading provider of diagnostic testing, inf... |
| | | 08/17/07 | Quest Diagnostics Declares Quarterly Cash Dividend| LYNDHURST, N.J., Aug. 17 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, today announced that its Board of Directors declared
a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per
share, payable on October 17, 2007, to shareholders of record on October 3,
2007.
About Quest Diagnostics
Quest Diagnostics is the leading provider of diagnostic testing,
informati... |
| | | 08/09/07 | Quest Diagnostics Drug Testing Index(R) Finds Cocaine Use at 10-Year Low Among U.S. Workers| Double-digit declines reported across the U.S.LYNDHURST, N.J., Aug 09, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- An unprecedented decline
in cocaine use by American workers drove use of the illicit drug to a new low
during the first half of 2007, according to the "Quest Diagnostics Drug
Testing Index: Cocaine Use Among America's Workers -- A Special 2007 Mid-Year
Report." Released today by Quest Diagnostics Incorporated (NYSE: DGX), the
nation's leading provider of diagnostic ... |
| | | 07/24/07 | Quest Diagnostics Reports Second Quarter 2007 Results| LYNDHURST, N.J., July 24 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that for the second quarter ended June 30,
2007, income from continuing operations was $142 million, or $0.73 per diluted
share, compared to $156 million, or $0.78 per diluted share, in the second
quarter of 2006. The second quarter of 2007 includes the results of AmeriPath,
Inc., which was acquired on Ma... |
| | | 07/19/07 | Quest Diagnostics Announces New Testing Technique for Improved Diagnosis of Metabolic And Nutritional Disorders| LYNDHURST, N.J., July 19 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, today announced a new, proprietary diagnostic
testing technique to help physicians diagnose genetic metabolic disorders,
such as phenylketonuria (PKU) and homocystinuria. Genetic metabolic disorders
can impair a child's mental and physical development. The new technique
measures amino acids in blood plasma, urine ... |
| | | 07/17/07 | Quest Diagnostics Launches National Patient Appointment Scheduling| Industry's first national scheduling system provides convenient scheduling
options and reduced wait times for patients
LYNDHURST, N.J., July 17 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, today announced the first national patient
appointment-scheduling system in the diagnostic testing service industry. The
new system gives patients the option to schedule appointm... |
| | | 06/23/07 | Diabetes Patients Make Significant Gains in Disease Control; Still, Nearly Half Fail to Reach ADA Treatment Goals|
Gains come soon after diagnosis then plateau; young male adults fare worse
than females
Test results found to worsen in winter
Six-year data released from nation's largest laboratory testing database
CHICAGO, June 23 /PRNewswire/ -- Over the last six years, Americans being
treated for diabetes improved control of their disease by a significant 44.4
percent. As of December, 2006, more than half (54.6 percent) had reached
... |
| | | 06/22/07 | Quest Diagnostics to Speak at the Jefferies Healthcare Conference| LYNDHURST, N.J., June 22 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the
Jefferies Healthcare Conference on Tuesday, June 26, 2007. The Quest
Diagnostics presentation is scheduled to begin at 9:50 a.m. Eastern Time.
The presentation will be webcast live during the conference and will be
available to registered investors on the following... |
| | | 06/20/07 | Quest Diagnostics Announces Pricing of Senior Notes| LYNDHURST, N.J., June 20 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information, and services, announced today that it priced $800 million in
aggregate principal amount of senior notes in a public offering. The notes
were sold in two tranches, as follows: $375 million of 6.40% senior notes due
2017 and $425 million of 6.95% senior notes due 2037. The offering is expected
to close on June 22, 2007. The net p... |
| | | 06/19/07 | Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering| LYNDHURST, N.J., June 19 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information, and services, announced today that it intends to offer
$800,000,000 in aggregate principal amount in two series of senior notes, in a
public offering made under a shelf registration statement filed with the
Securities and Exchange Commission, subject to market and other conditions.
The notes will be fully and unconditionally gu... |
| | | 06/19/07 | Quest Diagnostics Incorporated Announces Completion of Tender Offer for the 10 1/2% Senior Subordinated Notes Due 2013 of AmeriPath, Inc.| LYNDHURST, N.J., June 19 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostics
testing, information and services, announced today that it has completed its
cash tender offer for the outstanding $350 million, 10 1/2% Senior
Subordinated Notes due 2013 (the "Notes") (CUSIP Nos. 03071D AC 3 and 03071D
AA 7) of AmeriPath, Inc. ("AmeriPath"). The cash tender offer expired, as
scheduled, on June 18, 2007, at 12:00 midnight, ET, (t... |
| | | 06/07/07 | Quest Diagnostics Extends Agreement With CIGNA Healthcare| LYNDHURST, N.J., June 7 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that it has signed a multi-year
contract extension with CIGNA HealthCare and will remain a participating
provider in all markets for all products. Quest Diagnostics is the largest
provider of laboratory services to CIGNA HealthCare, providing its members and
providers with the nation's broadest acces... |
| | | 06/05/07 | Quest Diagnostics Incorporated Announces Pricing and Receipt of Requisite Consents for Cash Tender Offer and Consent Solicitation for the 10 1/2% Senior Subordinated Notes Due 2013 of AmeriPath, Inc.| LYNDHURST, N.J., June 5 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostics
testing, information and services, announced today the determination of
pricing in connection with its cash tender offer and consent solicitation for
any and all of the outstanding $350,000,000 principal amount 10 1/2% Senior
Subordinated Notes due 2013 (the "Notes") (CUSIP Nos. 03071D AC 3 and 03071D
AA 7) of AmeriPath, Inc. ("AmeriPath").
The... |
| | | 05/31/07 | Quest Diagnostics Completes Acquisition of AmeriPath| LYNDHURST, N.J., MAY 31, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the leading provider of diagnostic testing,
information and services, announced that today it completed its previously
announced acquisition of AmeriPath, Inc., a national diagnostic testing
company.
"This acquisition creates the world's premier cancer diagnostics company
focused on dermatopathology, anatomic pathology and molecular diagnostics,"
said Surya N. Mohapa... |
| | | 05/30/07 | Quest Diagnostics Plans to Complete Acquisition of AmeriPath on May 31| LYNDHURST, N.J., May 30 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the leading provider of diagnostic testing,
information and services, announced today that it plans to complete its
previously announced acquisition of AmeriPath, Inc. on May 31, 2007. The
waiting period under the Hart-Scott-Rodino Antitrust Improvements Act expired
on May 29, 2007.
About AmeriPath
AmeriPath, a leading national provider of physician-based anatomic
pathology, derm... |
| | | 05/29/07 | Quest Diagnostics to Speak at the Bank of America Healthcare Conference 2007| LYNDHURST, N.J., May 29 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the Bank
of America Healthcare Conference on Thursday, May 31, 2007, at the Four
Seasons Hotel in Las Vegas, Nevada. The Quest Diagnostics presentation is
scheduled to begin at 5:40 p.m. Eastern Time.
During the conference, the company will reiterate its 2007 guidance f... |
| | | 05/21/07 | Study Reports Point-of-Care Test to be as Accurate as Conventional Laboratory Analysis in Detecting Kidney Disease in Patients with Diabetes and Cardiovascular Disease| CHICAGO, May 21 /PRNewswire-FirstCall/ -- A study presented today at the
American Society of Hypertension, Inc. (ASH) Twenty-Second Annual Scientific
Meeting and Exposition (ASH 2007) in Chicago reports that the HemoCue Albumin
201 system, a point-of-care diagnostic test developed by HemoCue AB, can
detect microalbuminuria, a biological marker for kidney and cardiovascular
disease as accurately as conventional laboratory tests. HemoCue, a Quest
Diagnostics (NYSE: DGX) company, is the d... |
| | | 05/21/07 | Quest Diagnostics Commences Cash Tender Offer for AmeriPath 10 1/2% Senior Subordinated Notes Due 2013| LYNDHURST, N.J., May 21 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostics
testing, information and services, announced today that it has commenced a
cash tender offer for all of the outstanding $350,000,000 principal amount
10 1/2% Senior Subordinated Notes due 2013 (CUSIP Nos. 03071D AC 3 and 03071D
AA 7) of AmeriPath, Inc. (AmeriPath). The tender offer is being made by Quest
Diagnostics in connection with its previousl... |
| | | 05/10/07 | Award for 'Best Employer for Healthy Lifestyles' Given to Quest Diagnostics| HealthyQuest Employee Wellness Program Features Unique
Combination of Diagnostic Screening, Lifestyle Assessment and Health Education
LYNDHURST, N.J., May 10 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the leading provider of diagnostic testing,
information and services, announced today that the National Business Group on
Health, an association of 266 large U.S. employers, has awarded its 2007 Best
Employers for Healthy Lifestyles Gold Award to the... |
| | | 05/08/07 | Quest Diagnostics Declares Quarterly Cash Dividend| LYNDHURST, N.J., May 8 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, today announced that its Board of Directors declared
a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per
share, payable on July 18, 2007, to shareholders of record on July 5, 2007.
About Quest Diagnostics
Quest Diagnostics is the leading provider of diagnostic testing,
information and se... |
| | | 04/19/07 | Quest Diagnostics Reports First Quarter 2007 Results| LYNDHURST, N.J., April 19 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that for the first quarter ended March 31,
2007, income from continuing operations was $108 million, or $0.55 per diluted
share compared to $155 million, or $0.77 per diluted share in the first
quarter of 2006.
Earnings in the first quarter were reduced by an estimated $0.17 per share
as a result of... |
| | | 04/17/07 | Quest Diagnostics' MedPlus(R) Subsidiary Selected To Develop The Lab Information System For The Province of British Columbia's Electronic Health Record System| One of North America's largest electronic health networks will deliver better care at lower costLYNDHURST, N.J., April 17, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics
Incorporated (NYSE: DGX) today announced that its healthcare information
technology subsidiary MedPlus, Inc., has been selected as a subcontractor by
Sun Microsystems (B.C.) Inc., a subsidiary of Sun Microsystems of Canada Inc.,
and subcontractors to develop and implement a comprehensive electronic
... |
| | | 04/16/07 | Quest Diagnostics to Acquire AmeriPath in a Transaction Valued at $2 Billion|
-- Establishes Leading Position in Cancer Diagnostics with a Focus on
Dermatopathology, Anatomic Pathology and Molecular Diagnostics --
-- Strengthens Leadership in Hospital and Esoteric Testing --
-- Enhances Position as World's Premier Diagnostic Testing Company --
LYNDHURST, N.J. and PALM BEACH GARDENS, Fla., April 16
/PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the
leading provider of diagnostic testing, information and service... |
| | | 03/22/07 | Quest Diagnostics Selected as Sole Laboratory Service Provider to National Health Service Hospital and Primary Care Trust| Agreement strengthens company's U.K. presence
LYNDHURST, N.J., March 22 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the leading U.S. provider of diagnostic testing,
information and services, announced today that it has been awarded a new,
five-year contract with the U.K.'s National Health Service West Middlesex
University Hospital Trust and the Hounslow Primary Care Trust of London to
provide end-to-end diagnostic testing and related support se... |
| | | 03/15/07 | Quest Diagnostics to Speak at the Lehman Brothers Tenth Annual Healthcare Conference| LYNDHURST, N.J., March 15 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the
Lehman Brothers Tenth Annual Healthcare Conference on Monday, March 19, 2007,
at the Loews Miami Beach Hotel in Miami, Florida. The Quest Diagnostics
presentation is scheduled to begin at 4:15 p.m. Eastern Time.
The presentation will be webcast live during the con... |
| | | 03/07/07 | Drug Use Hits New Low Among U.S. Workers in 2006, According to Quest Diagnostics' Drug Testing Index(R)| -- Lowest levels since 1988 --
-- Significant decline in use of amphetamines and marijuana continues trend
from previous year --
LYNDHURST, N.J., March 7 /PRNewswire-FirstCall/ -- A continued decline in
drug positivity for the amphetamine class of drugs among safety-sensitive
workers, coupled with a decrease in positive marijuana drug test results among
the general U.S. workforce, drove workplace drug use to a new low in 2006.
The... |
| | | 03/05/07 | Focus Diagnostics Receives FDA Clearance to Market Plexus HerpeSelect|
Focus Diagnostics Receives FDA Clearance to Market Plexus HerpeSelect
Monday March 5, 6:30 pm ET
CYPRESS, Calif., March 5 /PRNewswire-FirstCall/ -- Focus Diagnostics,
Inc., a wholly owned subsidiary of Quest Diagnostics Incorporated,
(NYSE: DGX - News), today announced it has received FDA 510k clearance to market its
new Plexus(TM) HerpeSelect® 1 and 2 IgG test kit, the first multiplex type-
specific HSV serology panel using xMAP® technology from Luminex Corporation.
Focus Diagnostics... |
| | | 02/22/07 | MedPlus' ChartMaxx(R) Earns Top Ranking in the '2006 Top 20 Year-End Best in KLAS' Report for Third Consecutive Year| LYNDHURST, N.J., Feb. 22 /PRNewswire-FirstCall/ -- MedPlus' ChartMaxx(R),
an enterprise-wide electronic health record solution for hospitals, Integrated
Delivery Networks and healthcare communities, placed first in Document
Management and Imaging (DMI) in the "2006 Top 20: Year-End Best in KLAS"
report issued by KLAS Enterprises. ((C) 2006 KLAS Enterprises, LLC. All rights
reserved). This marks the third consecutive year and fourth time in five
years that ChartMaxx has placed first in... |
| | | 02/14/07 | National Survey Shows Physicians Have Clear Preference Between the Two Largest Diagnostic Laboratories| - Results show overwhelming preference for Quest Diagnostics -
LYNDHURST, N.J., Feb. 14 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the leading provider of diagnostic testing,
information and services, announced today results of a national physician
study on preference and performance of medical laboratory services. When
physicians were asked which of the two largest national laboratories they
preferred, the majority of physicians expressed a preferenc... |
| | | 02/13/07 | Quest Diagnostics Declares Quarterly Cash Dividend| LYNDHURST, N.J., Feb. 13 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, today announced that its Board of Directors declared
a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per
share, payable on April 18, 2007, to shareholders of record on April 4, 2007.
About Quest Diagnostics
Quest Diagnostics is the leading provider of diagnostic testing,
information an... |
| | | 02/01/07 | Quest Diagnostics Acquires HemoCue for Approximately $420 Million, Entering Market for Near Patient Testing| LYNDHURST, N.J., Feb. 1 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the leading U.S. provider of diagnostic testing,
information and services, announced today that it has acquired HemoCue, a
Swedish company specializing in near patient testing, also known as point-of-
care testing, from the private equity firm EQT II B.V. in a cash transaction
valued at approximately $420 million. The acquisition will allow Quest
Diagnostics to enter the growing near patient t... |
| | | 01/29/07 | Quest Diagnostics to Speak at Wachovia Securities 2007 Healthcare Conference| LYNDHURST, N.J., Jan. 29 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the
Wachovia Securities 2007 Healthcare Conference on Tuesday, January 30, 2007,
at the Langham Hotel, Boston, Massachusetts. The Quest Diagnostics
presentation is scheduled to begin at 8:30 a.m. Eastern Time.
The presentation will be webcast live during the conferenc... |
| | | 01/25/07 | Quest Diagnostics Reports Strong Results for Fourth Quarter and Full Year 2006| - Company provides 2007 guidance -
LYNDHURST, N.J., Jan. 25 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that for the fourth quarter ended December
31, 2006, income from continuing operations was $151 million, or $0.77 per
diluted share compared to $149 million, or $0.73 per diluted share for the
prior year.
Fourth quarter revenues from continuing... |
| | | 01/19/07 | Quest Diagnostics Announces Licensing Agreement for Genetic Testing Technology to Screen for Most Common Inherited Mental Impairment, Fragile X Syndrome| New Technology Will Allow for Widespread Population-Based Carrier Screenings
LYNDHURST, N.J., Jan. 19 /PRNewswire-FirstCall/ -- In a move that promises
to advance physicians' ability to widely screen for Fragile X Syndrome (FXS),
the most common form of inherited mental retardation,(1) Quest Diagnostics
Incorporated (NYSE: DGX) today announced the signing of a worldwide license
agreement with U.S. Genomics. The terms grant Quest Diagnostics rights to
develop an advanced screening meth... |
| | | 01/09/07 | Quest Diagnostics to Speak at the 25th Annual JPMorgan Healthcare Conference| LYNDHURST, N.J., Jan 09, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the 25th
Annual JPMorgan Healthcare Conference on Wednesday, January 10, 2007, at the
Westin St. Francis in San Francisco, California. The Quest Diagnostics
presentation is scheduled to begin at 12:30 p.m. Eastern Time.
The presentation will be web... |
| | | 12/14/06 | Quest Diagnostics Declares Quarterly Cash Dividend| LYNDHURST, N.J., Dec. 14 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, today announced that its Board of Directors declared
a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per
share, payable on January 24, 2007, to shareholders of record on January 10,
2007.
About Quest Diagnostics
Quest Diagnostics is the leading provider of diagnostic testing,
informat... |
| | | 12/14/06 | Quest Diagnostics Launches Test to Help Oncologists Predict Risk of Breast Cancer Recurrence in Women with Estrogen Receptor (ER)-Positive, Lymph Node- Negative Cancers| SAN ANTONIO, Dec. 14 /PRNewswire-FirstCall/ -- Clinicians will have a new
prognostic tool in the battle against breast cancer, as Quest Diagnostics
Incorporated (NYSE: DGX) announced today that it has introduced its newly
developed test, the Breast Cancer Gene Expression Ratio (HOXB13:IL17BR), to
help physicians predict the risk of disease recurrence in women with estrogen
receptor (ER)-positive, lymph node-negative breast cancer. Quest Diagnostics
is the first company to develop a bre... |
| | | 11/14/06 | Ronald D. Luff, M.D., Recognized By the American Society of Cytopathology for Groundbreaking Work in Diagnosis of Cervical Disease| - Quest Diagnostics Physician Receives 2006 Papanicolaou Award for
Achievements in Cellular Pathology and Disease -
LYNDHURST, N.J., Nov. 14 /PRNewswire-FirstCall/ -- A pioneer in the
science and standardization of cervical disease diagnosis, Ronald D. Luff,
M.D., M.P.H, and Director of Anatomic Clinical Trials at Quest Diagnostics
(NYSE: DGX), recently received a lifetime achievement honor -- the 2006
Papanicolaou Award -- from the American Society of Cytopatholog... |
| | | 11/02/06 | New Study Shows InSure(R) Colorectal Cancer Screening Test Significantly Better at Detecting Early Stage Colorectal Cancers Compared to Traditional Test| The InSure Test Should Help Reduce Colorectal Cancer Mortality and Incidence
LYNDHURST, N.J., Nov. 2 /PRNewswire-FirstCall/ -- A study published in the
journal CANCER found that InSure,(R) a Fecal Immunochemical Test (FIT) from
Quest Diagnostics Incorporated (NYSE: DGX) detected three times as many early-
stage colorectal cancers and nearly two times as many significant (pre-
cancerous) adenomas compared to Hemoccult II Sensa(R)(1), the traditional
guaiac fecal occult blood test.(2)
... |
| | | 10/19/06 | Quest Diagnostics Reports Strong Performance in Third Quarter 2006 on 16% Revenue Growth| LYNDHURST, N.J., Oct 19, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that for the third quarter ended September
30, 2006, income from continuing operations was $164 million, or $0.82 per
diluted share compared to $140 million, or $0.68 per diluted share for the
prior year. Net income for 2006 was reduced by $13 million of pretax
expenses, or $0.04... |
| | | 10/03/06 | Quest Diagnostics to No Longer Be a National Contracted Provider of Lab Services to UnitedHealthcare Effective 2007| - Quest Diagnostics expects to continue to service UnitedHealthcare members as
a non-contracted provider of high quality convenient laboratory services -
LYNDHURST, N.J., Oct. 3 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it will not be a national contracted
provider of laboratory services to UnitedHealthcare beginning January 1, 2007.
UnitedHealthcare accounts for ... |
| | | 09/22/06 | Quest Diagnostics to Speak at the UBS Global Life Sciences Conference| LYNDHURST, N.J., Sept. 22 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the UBS
Global Life Sciences Conference on Monday, September 25, 2006, at the Grand
Hyatt New York Hotel. The Quest Diagnostics presentation is scheduled to begin
at 8:00 a.m. Eastern Time.
The presentation will be webcast live during the conference and will be
avail... |
| | | 09/19/06 | Quest Diagnostics Again Selected as Part of Dow Jones Sustainability World Index| - Company is also Selected for Inclusion in the DJSI North America Index -
LYNDHURST, N.J., Sept. 19 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it was again selected to be part of
the Dow Jones Sustainability (DJSI) World and North American Indexes. The
company was first added to the World Index in 2004 and the North American
Index in 2005.
"We are delighted t... |
| | | 09/07/06 | Quest Diagnostics Acquires Maker of InSure(R) Colorectal Cancer Screening Test| LYNDHURST, N.J., Sept. 7 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it has completed the acquisition of
Enterix, Inc., the privately held Australian-based company that developed and
manufactures the InSure(R) Fecal Immunochemical Test (F.I.T.), an FDA-cleared
test for use in screening for colorectal cancer and other sources of lower
gastrointestinal bleeding, for app... |
| | | 09/06/06 | Quest Diagnostics to Speak at the Thomas Weisel Partners Healthcare Conference 2006| LYNDHURST, N.J., Sept. 6 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the
Thomas Weisel Partners Healthcare Conference on Thursday, September 7, 2006,
at the Four Seasons Boston in Boston, Massachusetts. The Quest Diagnostics
presentation is scheduled to begin at 2:05 p.m. Eastern Time.
During the conference, the company will reiterate i... |
| | | 09/06/06 | Cincinnati Children's Hospital Medical Center Selects ChartMaxx(R) for its Health Information Management Department| LYNDHURST, N.J., Sept. 6 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that Cincinnati Children's Hospital
Medical Center has selected MedPlus' ChartMaxx(R) electronic health record
solution to support its Health Information Management department with document
management and imaging. ChartMaxx was developed by MedPlus, Quest
Diagnostics' healthcare information technol... |
| | | 08/21/06 | Quest Diagnostics' MedPlus(R) Subsidiary Earns Top Ranking in KLAS Mid-Year Report For Its ChartMaxx(R) Electronic Patient Record Solution| LYNDHURST, N.J., Aug. 21 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that its MedPlus healthcare
information technology subsidiary has been recognized as the number one
Document Management and Imaging (DMI) vendor in the 2006 "Top 20: KLAS
Mid-Year Report Card." ((C)2006 KLAS Enterprises, LLC. All rights reserved.)
This top ranking position marks the fourth time the... |
| | | 08/09/06 | Quest Diagnostics Declares Quarterly Cash Dividend| LYNDHURST, N.J., Aug. 9 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, today announced that its Board of Directors declared
a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per
share, payable on October 18, 2006, to shareholders of record on October 4,
2006.
About Quest Diagnostics
Quest Diagnostics is the leading provider of diagnostic testing,
informatio... |
| | | 08/02/06 | Quest Diagnostics Reopens Louisiana Laboratory Damaged by Hurricane Katrina| NEW ORLEANS, Aug. 2 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced it has reopened its laboratory in
Metairie, Louisiana, after successfully completing reconstruction to the
facility following substantial damage to the building and testing equipment
caused by Hurricane Katrina.
Quest Diagnostics' Metairie laboratory performs rapid-response testing as
well as anatomic pat... |
| | | 07/24/06 | Quest Diagnostics Reports Strong Performance In Second Quarter 2006 On 15% Revenue Growth| LYNDHURST, N.J., July 24 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that for the second quarter ended June 30,
2006, net income was $156 million, or $0.78 per diluted share, excluding the
performance of NID, the company's test kit manufacturing subsidiary, whose
operations are being discontinued. NID's performance reduced pretax earnings
by $35 million, or $0.12 per shar... |
| | | 07/05/06 | Quest Diagnostics Completes Acquisition of Focus Diagnostics, Inc., a World Leader in Infectious Disease Testing| LYNDHURST, N.J., July 5 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, has completed the previously announced acquisition
of Focus Diagnostics, Inc., in a cash transaction valued at approximately $185
million.
Focus Diagnostics is recognized worldwide for its leadership in infectious
and immunologic diseases and has established a reputation for being first to
introduce new assays ... |
| | | 06/19/06 | Amphetamines Use Declined Significantly Among U.S. Workers in 2005, According to Quest Diagnostics' Drug Testing Index| - Drug Use Among Workers Declines to 17-year Low in 2005 -
LYNDHURST, N.J., June 19 /PRNewswire-FirstCall/ -- Amphetamines use, which
includes amphetamine and methamphetamine, declined significantly among general
U.S. workforce employees during 2005, according to the semi-annual Drug
Testing Index, released today by Quest Diagnostics Incorporated (NYSE: DGX),
the leading provider of employer drug testing services in the United States.
The findings were based on the results of... |
| | | 05/19/06 | Quest Diagnostics to Acquire Focus Diagnostics, Inc., A World Leader in Infectious Disease Testing| LYNDHURST, N.J., and HERNDON, Va., May 19 /PRNewswire-FirstCall/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, has agreed to acquire Focus
Diagnostics, Inc., the premier infectious disease testing provider, in a cash
transaction valued at approximately $185 million. Focus Diagnostics is
privately held and based in Herndon, Virginia. The acquisition will add annual
revenues of approximately $65 million.
... |
| | | 05/15/06 | Quest Diagnostics to Speak at the Bank of America Healthcare Conference 2006| LYNDHURST, N.J., May 15 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the Bank
of America Healthcare Conference on Wednesday, May 17, 2006, at the Four
Seasons Hotel in Las Vegas, Nevada. The Quest Diagnostics presentation is
scheduled to begin at 11:40 a.m. Eastern Time.
During the conference, the company will reiterate its 2006 guidance... |
| | | 05/10/06 | Quest Diagnostics Declares Quarterly Cash Dividend| LYNDHURST, N.J., May 10 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, today announced that its Board of Directors declared
a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per
share, payable on July 21, 2006, to shareholders of record on July 7, 2006.
About Quest Diagnostics
Quest Diagnostics is the leading provider of diagnostic testing,
information and s... |
| | | 05/05/06 | A.O. Fox Hospital Physicians Now Armed with ChartMaxx(R), an Electronic Health Record Solution, to Deliver Optimum Patient Care| LYNDHURST, N.J., and ONEONTA, N.Y., May 5 /PRNewswire-FirstCall/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, and A.O. Fox Hospital, Oneonta's
largest healthcare provider, today announced the successful implementation of
ChartMaxx(R), an electronic health record solution at A.O. Fox's hospital and
offsite care centers. ChartMaxx was developed by MedPlus(R), Quest
Diagnostics' healthcare information techno... |
| | | 05/03/06 | Patients Improved Diabetes Control Over 5-Year Period, But Many Fail to Achieve Treatment Goal| Quest Diagnostics Health Trends(TM) Diabetes Report Is Based on 14.3
Million Test Results From 2001 - 2005 From the Nation's Largest Database of Clinical Lab Results
LYNDHURST, N.J., May 3 /PRNewswire/ -- People with diabetes who visit
health professionals are doing a better job of managing their disease,
according to results from the Quest Diagnostics Health Trends (TM) Diabetes
Report. However, the Report also found that nearly half of all test results
in 2... |
| | | 05/01/06 | Quest Diagnostics' Healthcare Information Technology Subsidiary to Test ePrescribing Technology Standards in Two New Pilot Programs| LYNDHURST, N.J., May 1 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic
laboratory testing, information and services, announced today that its
healthcare information technology subsidiary, MedPlus, will test electronic
prescribing standards in two new pilot programs starting in May.
MedPlus will conduct testing in pilot programs in New Jersey and Florida
that are designed to research the function and interoperability ... |
| | | 04/20/06 | Quest Diagnostics Reports Strong Performance in First Quarter 2006| - Revenues grew 18% and earnings per share grew 13% -
LYNDHURST, N.J., April 20 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that for the first quarter ended March 31,
2006, net income increased to $145 million from $132 million in the first
quarter of 2005. Earnings per diluted share increased 13% to $0.72 from $0.64
a year ago. Included in the 2006 results wer... |
| | | 03/28/06 | Quest Diagnostics Launches the First Tests to Help Doctors Assess Status of Leukemia and Lymphoma in Patients Using Blood Plasma Instead of Bone Marrow| - LEUMETA Cancer Tests Are Less Invasive Than Bone Marrow Biopsies, Providing
Doctors With New Tools to More Frequently Assess Disease Progress and Help the Physician Tailor Cancer Therapy to Individual Needs -
LYNDHURST, N.J., March 28 /PRNewswire-FirstCall/ -- Nearly 1 million
Americans who are battling or recovering from leukemia and lymphoma have a
powerful new diagnostic tool available as Quest Diagnostics Incorporated
(NYSE: DGX) today launches the first of its LEUMETA(TM) cancer ... |
| | | 03/09/06 | Quest Diagnostics to Speak at The Lehman Brothers Ninth Annual Healthcare Conference| LYNDHURST, N.J., March 9 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the
Lehman Brothers Ninth Annual Healthcare Conference on Friday, March 10, 2006,
at the Loews Miami Beach Hotel in Miami, Florida. The Quest Diagnostics
presentation is scheduled to begin at 8:00 a.m. Eastern Time.
The presentation will be webcast live during the conf... |
| | | 02/13/06 | Quest Diagnostics' Enhanced Care360(TM) Physician Portal Combines Laboratory Test Results and Prescription Data to Help Doctors Evaluate Patients' Response to Medication Therapy| - See an introductory demonstration at MedPlus booth # 2527 at the HIMSS
conference, February 13 - 16 in San Diego -
LYNDHURST, N.J., Feb. 13 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic
laboratory testing, information and services announced today that its enhanced
Care360 Physician Portal now combines laboratory test results and prescription
data to help doctors evaluate patients' response to medi... |
| | | 01/26/06 | Quest Diagnostics Reports Strong Financial Results in Fourth Quarter and Full Year 2005| - 2006 earnings per share expected to grow to $2.75 to $2.85,
after $0.20 per share estimated cost of SFAS 123R -
LYNDHURST, N.J., Jan. 26 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that for the fourth quarter ended December
31, 2005, net income increased to $130 million, or $0.64 per diluted share,
compared to $126 million, or $0.60 per share in 2004... |
| | | 01/26/06 | Quest Diagnostics Expands Share Repurchase Authorization by $600 Million and Increases Quarterly Dividend| LYNDHURST, N.J., Jan. 26 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that its Board of Directors expanded its
share repurchase authorization by an additional $600 million, bringing the
total amount authorized and available for repurchases to $722 million. During
2005 the company repurchased 7.8 million common shares for $390 million. The
company had approximately 199 milli... |
| | | 01/13/06 | Quest Diagnostics' MedPlus® Subsidiary Earns Top Ranking in KLAS Industry Report for Its ChartMaxx® Solution| ChartMaxx Receives '2005 BEST IN KLAS' Award in the Document Management & Imaging CategoryLYNDHURST, N.J., Jan 13, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, today announced that its MedPlus healthcare
information technology subsidiary was recognized among healthcare IT
executives, as the number one Document Management and Imaging (DMI) vendor in
the 2005 "T... |
| | | 01/09/06 | Quest Diagnostics to Speak at the 24th Annual JPMorgan Healthcare Conference| LYNDHURST, N.J., Jan. 9 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the 24th
Annual JPMorgan Healthcare Conference on Tuesday, January 10, 2006, at the
Westin St. Francis in San Francisco, California. The Quest Diagnostics
presentation is scheduled to begin at 2:30 p.m. Eastern Time.
The presentation will be webcast live during the conf... |
| | | 12/13/05 | Quest Diagnostics Declares Quarterly Dividend| LYNDHURST, N.J., Dec. 13 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that its Board of Directors has declared a
quarterly cash dividend on Quest Diagnostics common stock of $0.09 per share,
payable on January 25, 2006 to shareholders of record on January 11, 2006.
Quest Diagnostics is the leading provider of diagnostic testing,
information and services that patients an... |
| | | 12/09/05 | Quest Diagnostics Unveils New Data Confirming Benefits Of Leukemia Tests Using Blood Plasma, Compared With Conventional Tests Using Cells In Bone Marrow Or Blood, At American Society Of Hematology Meeting| 23 Quest Diagnostics abstracts demonstrate scientific leadership with data highlighting effectiveness of newer, more sensitive, less invasive tests to diagnose and monitor hematologic disease
LYNDHURST, N.J., Dec. 9 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that it is presenting new data on a
new series of laboratory-developed diagnostic assays for hematologic di... |
| | | 12/09/05 | Quest Diagnostics Announces the Availability of a New Gene-Based Assay To Help Physicians Identify the Primary Site of a Metastatic Cancer of Unknown Origin| LYNDHURST, N.J., Dec. 9 /PRNewswire-FirstCall/ -- Quest Diagnostics
(NYSE: DGX), the nation's leading provider of diagnostic laboratory testing,
information and services, announced today that it has developed a new gene-
based assay to help physicians identify metastatic Cancers of Unknown Primary
origin (CUP). This laboratory-developed assay is currently available to
physicians through Quest Diagnostics Nichols Institute, the company's esoteric
testing laboratory, in San Juan Capistra... |
| | | 12/01/05 | Amphetamines Drug-Test Positives Are Up Among Safety-Sensitive Workers in the First Half of 2005, According to Quest Diagnostics' Drug Testing Index(R)| - Overall Decline in Positive Drug Tests Linked to Decrease in Marijuana
Positivity -
LYNDHURST, N.J., Dec. 1 /PRNewswire-FirstCall/ -- The proportion of drug-
test positives for amphetamines increased among workers subject to federal
testing regulations, while overall drug-test positives decreased among all
U.S. workers in the first half of 2005, according to the semi-annual Drug
Testing Index(R) released today by Quest Diagnostics Incorporated (NYS... |
| | | 11/28/05 | Quest Diagnostics to Speak at the Merrill Lynch Health Services Investor Conference| LYNDHURST, N.J., Nov 28, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the
Merrill Lynch Health Services Investor Conference on Tuesday, November 29,
2005, at The Waldorf Astoria Hotel in New York City. The Quest Diagnostics
presentation is scheduled to begin at 8:45 a.m. Eastern Time.
During the conference, the co... |
| | | 11/22/05 | Quest Diagnostics' Care360 Physician Portal Offers Electronic Prescribing Tools for Pennsylvania Physicians Participating in Highmark eHealth Collaborative| ~ Foundation provides incentives for physicians to adopt electronic prescribing technology ~LYNDHURST, N.J., Nov 22, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics
(NYSE: DGX), the nation's leading provider of diagnostic laboratory testing,
information and services announced today that its Care360(TM) Physician Portal
is one of the preferred electronic health tools for Pennsylvania physicians
who receive funding from the Highmark eHealth Collaborative, a physician
... |
| | | 11/17/05 | Quest Diagnostics, in Cooperation with AARP, Opens Doors for Older Job Seekers| Featured Employers Program Brings Value to 50+ Workers and Quest Diagnostics
LYNDHURST, N.J., Nov. 17 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, today announced that it has been named one of AARP's
Featured Employers, a program designed to help Americans aged 50 and over
remain in the workforce as desired. The new Featured Employers are committed
to an aggressive program of recrui... |
| | | 11/04/05 | Quest Diagnostics to Speak at the CIBC World Markets Sixteenth Annual Healthcare Conference| LYNDHURST, N.J., Nov. 4 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the CIBC
World Markets Sixteenth Annual Healthcare Conference on Tuesday, November 8,
2005, at The Waldorf Astoria Hotel in New York City. The Quest Diagnostics
presentation is scheduled to begin at 10:00 a.m. Eastern Time.
The presentation will be webcast live during t... |
| | | 11/03/05 | Quest Diagnostics Offers Test to Detect Avian Influenza Virus| LYNDHURST, N.J., Nov. 3 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, today announced that it has developed a diagnostic
test to detect the avian influenza virus and will participate in the
government's preparedness efforts to provide rapid diagnosis and early
surveillance of an outbreak, should the need arise.
Quest Diagnostics has notified physicians and hospitals that it has be... |
| | | 11/01/05 | Quest Diagnostics Completes Acquisition of LabOne| LYNDHURST, N.J., Nov 01, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics
Incorporated (NYSE: DGX) announced today that it had completed the all-cash
acquisition of LabOne, Inc. (Nasdaq: LABS) in a transaction valued at
$934 million. The acquisition was funded primarily with proceeds from the sale
of $900 million of senior notes on October 31, 2005.
Headquartered in Lenexa, Kansas, LabOne provides health screening and risk
assessment services to life insurance com... |
| | | 10/27/05 | LabOne Shareholders Vote to Approve Acquisition by Quest Diagnostics| LYNDHURST, N.J., and LENEXA, Kan., Oct 27, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest
Diagnostics Incorporated (NYSE: DGX) and LabOne, Inc. (Nasdaq: LABS) announced
that LabOne shareholders approved the acquisition of LabOne by Quest
Diagnostics in a vote held at a special meeting today.
The shareholder vote followed regulatory clearance of the transaction in
mid-October. The transaction is expected to be completed during the first week
of November.
"We are excited t... |
| | | 10/25/05 | Quest Diagnostics Announces Pricing Of Senior Notes| LYNDHURST, N.J., Oct. 25 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information, and services, announced today that it priced $900 million in
aggregate principal amount of senior notes in a private placement. The notes
were sold in two tranches, as follows: $400 million of 5.125% senior notes due
2010 and $500 million of 5.45% senior notes due 2015. The offering is
expected to close on October 31, 2005. ... |
| | | 10/25/05 | Quest Diagnostics Announces Proposed Senior Notes Offering| LYNDHURST, N.J., Oct. 25 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information, and services, announced today that it intends to offer
$900,000,000 in aggregate principal amount of senior notes, in a private
placement, subject to market and other conditions. The net proceeds of the
offering are expected to be used to complete the previously announced
acquisition of LabOne, Inc. (Nasdaq: LABS).
The no... |
| | | 10/20/05 | Quest Diagnostics Reports Strong Revenue Growth In Third Quarter 2005| - Earnings growth in third quarter and full year reduced by Gulf Coast hurricanes and performance of test kit manufacturing business -
LYNDHURST, N.J., Oct. 20 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that for the third quarter ended September
30, 2005, net income increased to $135 million or $0.66 per diluted share,
compared to $130 million, or $0.62 per diluted sha... |
| | | 10/10/05 | Average LDL Cholesterol Levels Decreased Approximately 10 Percent Among People Under Doctors' Care from 2001 to 2004| - Quest Diagnostics launches Health Trends(R), a national source of patient
health information that provides insights from the nation's largest private
database of clinical test results -
- Cholesterol levels decreased less in women than men -
LYNDHURST, N.J., Oct. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics
(NYSE: DGX), the nation's leading provider of diagnostic testing, information
and services, announced today that it identified a significant ... |
| | | 09/29/05 | Quest Diagnostics Again Selected as Part of Dow Jones Sustainability World Index| - Company Also Selected for Inclusion in
First DJSI North America Index -
LYNDHURST, N.J., Sept. 29 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it again was selected to be part of
the Dow Jones Sustainability World Index (DJSI World). The company was first
added to the index in 2004. In addition, Quest Diagnostics was selected... |
| | | 09/28/05 | Quest Diagnostics' MedPlus(R) Subsidiary Earns Top Ranking in KLAS Industry Report for Its ChartMaxx(R) Electronic Patient Record Solution| LYNDHURST, N.J., Sept 28, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that its MedPlus healthcare
information technology subsidiary has been recognized as the number one
Document Management and Imaging (DMI) vendor for its ChartMaxx(R) electronic
patient record solution in an industry report published by KLAS Enterprises,
LLC. KLAS is a heal... |
| | | 09/23/05 | Quest Diagnostics to Speak at the UBS Global Life Sciences Conference| LYNDHURST, N.J., Sept. 23 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the UBS
Global Life Sciences Conferences on Monday, September 26, 2005, at The Grand
Hyatt Hotel, in New York City. The Quest Diagnostics presentation is scheduled
to begin at 8:00 a.m. Eastern Time.
The presentation will be webcast live during the conference and will... |
| | | 09/08/05 | Fort Worth-Based North Texas Specialty Physicians Undertakes Major Technology Upgrade Among Its 600 Participating Doctors| - Technology upgrade will help enhance patient care and facilitate physicians'
move toward clinical integration -
FORT WORTH, Texas, and LYNDHURST, N.J., Sept. 8 /PRNewswire-FirstCall/ --
North Texas Specialty Physicians (NTSP) and Quest Diagnostics (NYSE: DGX), the
nation's leading provider of diagnostic testing, information and services,
announced today that NTSP physicians will use Quest Diagnostics' Care360
physician portal to better manage patients' laborat... |
| | | 09/08/05 | NID Wins Patent Dispute| SAN CLEMENTE, Calif., Sept. 8 /PRNewswire-FirstCall/ -- Nichols Institute
Diagnostics, Inc. (NID), a manufacturer of specialty diagnostic test kits and
systems, announced that the U.S. District Court for the Southern District of
California reversed part of a jury verdict and ruled decisively in favor of
NID in its patent infringement case against Scantibodies Clinical Laboratory,
Inc. and Scantibodies Laboratory, Inc.
NID has an exclusive license to a patent for an assay for measurin... |
| | | 09/08/05 | Quest Diagnostics to Speak at the Thomas Weisel Partners Tailwinds 2005 Conference| LYNDHURST, N.J., Sept. 8 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the
Thomas Weisel Partners Tailwinds Conference on Friday, September 9, 2005, at
The Four Seasons Hotel in Boston, Massachusetts. The Quest Diagnostics
presentation is scheduled to begin at 9:45 a.m. Eastern Time.
The presentation will be webcast live during the conferen... |
| | | 09/02/05 | Quest Diagnostics To Aid Hurricane Relief Efforts| LYNDHURST, N.J., Sept. 2 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced efforts to assist victims of Hurricane
Katrina.
The company has pledged $50,000 to the American Red Cross Hurricane 2005
Relief Fund. In addition, Quest Diagnostics employees have established a
special relief fund to aid their fellow employees along the Gulf Coast who
have been impacted by Hurricane Ka... |
| | | 08/10/05 | Quest Diagnostics Declares Quarterly Dividend| LYNDHURST, N.J., Aug. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that its Board of Directors has declared a
quarterly cash dividend on Quest Diagnostics common stock of $0.09 payable on
October 19, 2005 to shareholders of record on October 5, 2005. The per share
dividend reflects an earlier two-for-one stock split.
Quest Diagnostics is the leading provider of diagnost... |
| | | 08/10/05 | Quest Diagnostics Is Selected to Provide Confirmatory Testing for the California Department of Health Services Expanded Newborn Screening Program| LYNDHURST, N.J., Aug. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that it has signed an agreement with
the State of California Department of Health Services to provide follow-up
laboratory testing under the recently expanded Newborn Screening Program of
the agency's Genetic Disease Branch.
As part of the state's expanded Newborn Screening Program, Quest
Diagnos... |
| | | 08/08/05 | Quest Diagnostics to Acquire LabOne for $934 Million in Cash| - Transaction to generate significant synergies and expand geographic reach - - Establishes leading position in testing-related business serving life insurance industry - LYNDHURST, N.J. and LENEXA, Kan., Aug 08, 2005 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, announced today that it has
signed a definitive agreement to acquire LabOne, Inc. (Nasdaq: LABS). Under
the terms of ... |
| | | 08/08/05 | Jenne K. Britell, Ph.D., Elected to Quest Diagnostics Board| LYNDHURST, N.J., Aug 08, 2005 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that its Board of Directors has
elected Jenne K. Britell, Ph.D., to serve as a Director, increasing the Board
to 11 members.
Dr. Britell, 63, is Chairman and CEO of Structured Ventures, Inc., a
private company which advises venture capital firms and financial institutions
in both U.... |
| | | 08/03/05 | Quest Diagnostics' Care360 Physician Portal Connects to Retail Pharmacies Using the SureScripts Electronic Prescribing Network| - Connection Enables Two-Way Communication Between Physicians and Pharmacies -
ALEXANDRIA, Va. and LYNDHURST, N.J., Aug. 3 /PRNewswire-FirstCall/ --
SureScripts, the nation's largest network provider of electronic prescribing
services, and Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading
provider of diagnostic laboratory testing, information and services, announced
today that Quest Diagnostics' Care360 physician portal has established a
direct electronic connection to... |
| | | 07/25/05 | Quest Diagnostics Reports Strong Performance in Second Quarter 2005| LYNDHURST, N.J., July 25 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that for the second quarter ended June 30,
2005, net income increased to $149 million, compared to $135 million before
special charges of $13.2 million pre-tax, or $0.04 per diluted share, in the
second quarter last year. Earnings per diluted share increased 14% to $0.72 in
2005 from $0.63 before special char... |
| | | 07/22/05 | Ciphergen Biosystems and Quest Diagnostics Form Strategic Alliance to Develop and Commercialize Tests Using Ciphergen's Proteomics Technology| FREMONT, Calif. and LYNDHURST, N.J., July 22 /PRNewswire-FirstCall/ --
Ciphergen Biosystems, Inc. (Nasdaq: CIPH) and Quest Diagnostics Incorporated
(NYSE: DGX), the leading provider of diagnostic testing, information and
services in the U.S., announced the formation of a strategic alliance to
develop and commercialize novel proteomic diagnostic tests based on
Ciphergen's proprietary SELDI ProteinChip(R) technology.
The strategic alliance will focus on the commercialization of selecte... |
| | | 07/20/05 | Quest Diagnostics' MedPlus(R) Subsidiary Earns Top Ranking in KLAS Mid-Year Report for Its ChartMaxx(R) Electronic Patient Record Solution| LYNDHURST, N.J., July 20 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that its MedPlus healthcare
information technology subsidiary has been recognized as the number one
Document Management and Imaging (DMI) vendor in the 2005 "Top 20: KLAS
Mid-Year Report Card." ((C) 2005 KLAS Enterprises, LLC. All rights reserved.)
This top ranking marks the third time the company's Ch... |
| | | 07/13/05 | St. Joseph's Physicians Association Selects Quest Diagnostics' Care360 Physician Portal to Help Physicians Deliver Better Patient Care| MILWAUKEE and LYNDHURST, N.J., July 13, 2005 /PRNewswire-FirstCall via COMTEX/ -- St.
Joseph's Physicians Association (SJPA), an independent physicians association
(IPA) that comprises nearly 400 doctors in the greater Milwaukee metropolitan
area, today announced that it has selected Quest Diagnostics' Care360
physician portal to help its physician members deliver better patient care.
The Care360 physician portal enables physicians to order diagnostic tests
and review laboratory result... |
| | | 06/29/05 | Quest Diagnostics' Care360 Physician Portal Offers Electronic Health Tools for Physicians in Southeast Michigan E-Prescribing Initiative (Semi)| - Technology by Quest Diagnostics Subsidiary, MedPlus, Enables
Electronic Prescribing and Patient Recordkeeping -
LYNDHURST, N.J., June 29 /PRNewswire-FirstCall/ -- Quest Diagnostics
(NYSE: DGX), the nation's leading provider of diagnostic testing, information
and services, announced that its Care360 physician portal is one of the
preferred electronic health tools for physicians participating in the
Southeast Michigan E-Prescribing Initiative (SEMI), a physician incent... |
| | | 06/28/05 | Quest Diagnostics to Speak at the Wachovia Securities Fifteenth Annual Nantucket Equity Conference| LYNDHURST, N.J., June 28 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Robert A. Hagemann, Senior Vice
President and Chief Financial Officer, is scheduled to speak at the Wachovia
Securities Fifteenth Annual Nantucket Equity Conference on, Wednesday, June
29, 2005, at Harbor House Village, in Nantucket, Massachusetts. The Quest
Diagnostics presentation is scheduled to begin... |
| | | 05/16/05 | Quest Diagnostics to Speak at The Banc of America Securities Healthcare Conference| LYNDHURST, N.J., May 16 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Robert A. Hagemann, Senior Vice
President and Chief Financial Officer, is scheduled to speak at the Banc of
America Securities Healthcare Conference on Tuesday, May 17, 2005, at the Four
Seasons Hotel in Las Vegas, Nevada. The Quest Diagnostics presentation is
scheduled to begin at 5:00 p.m. Eastern Time.... |
| | | 05/16/05 | Amphetamines Use in the Workplace Continued to Grow, According to Quest Diagnostics' 2004 Drug Testing Index| LYNDHURST, N.J., May 16 /PRNewswire-FirstCall/-- The use of amphetamines
among general workforce employees continued to grow in 2004, according to the
semi-annual Drug Testing Index(R) released today by Quest Diagnostics
Incorporated (NYSE: DGX), the leading provider of employer drug testing
services in the United States.
Amphetamines use, which grew rapidly between 2000 and 2003, continued to
grow in 2004, although at a slower rate. Among general U.S. workforce
employees, the inci... |
| | | 05/10/05 | Quest Diagnostics Declares Two-For-One Stock Split and Quarterly Dividend| LYNDHURST, N.J., May 10 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that its Board of Directors has declared a
two-for-one stock split, in the form of a 100% stock dividend.
All shareholders of record on June 6, 2005 will receive one additional
share of common stock for each share held on that date. The additional shares
of common stock will be distributed to shareholder... |
| | | 04/29/05 | The Health Alliance(TM) of Greater Cincinnati Selects ChartMaxx(R) Electronic Health Record Solution to Automate its Patient Financial Services Department| LYNDHURST, N.J. and CINCINNATI, April 29 /PRNewswire-FirstCall/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, and The Health Alliance of
Greater Cincinnati, the region's largest healthcare provider, today announced
that ChartMaxx has been selected to automate Health Alliance's patient
financial services department. ChartMaxx is the electronic health record
solution developed by MedPlus(R), Quest Diagnostics' h... |
| | | 04/21/05 | Quest Diagnostics Reports Strong Performance in First Quarter 2005| LYNDHURST, N.J., April 21 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that for the first quarter ended March 31,
2005, net income increased to $132 million from $116 million in the first
quarter of 2004. Earnings per diluted share increased 19% to $1.28 from $1.08
a year ago. As previously disclosed, 2004 earnings per share reflect the
required change in accounting for the com... |
| | | 03/29/05 | Quest Diagnostics to Speak at the Lehman Brothers Annual Global Healthcare Conference| LYNDHURST, N.J., March 29 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Robert A. Hagemann, Senior Vice
President and Chief Financial Officer, is scheduled to speak at the Lehman
Brothers Annual Global Healthcare Conference on Wednesday, March 30, 2005, at
the Loews Miami Beach Hotel in Miami, Florida. The Quest Diagnostics
presentation is scheduled to begin at 3:45 p.m. Ea... |
| | | 02/14/05 | Quest Diagnostics to Speak at the UBS Global Healthcare Services Conference| TETERBORO, N.J., Feb 14, 2005 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Robert A. Hagemann, Senior Vice
President and Chief Financial Officer, is scheduled to speak at the UBS Global
Healthcare Services Conference on Tuesday, February 15, 2005, at The Plaza
Hotel in New York City, New York. The Quest Diagnostics presentation is
scheduled to begin at 8:00 a.m.... |
| | | 01/27/05 | Quest Diagnostics Reports Strong Financial Results in Fourth Quarter and Full Year 2004 -- Earnings per Share Expected to Grow 14-16% in 2005 | TETERBORO, N.J., Jan 27, 2005 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that for the fourth quarter ended December
31, 2004, net income increased to $126 million, compared to $108 million in
2003. Earnings per diluted share increased 21% to $1.23, before a required
change in accounting for the company's contingent convertible debentures.
After the change in accou... |
| | | 01/27/05 | Quest Diagnostics Increases Quarterly Dividend By 20% And Expands Share Repurchase Authorization By $350 Million| TETERBORO, N.J., Jan 27, 2005 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that its Board of Directors declared a
quarterly cash dividend of $0.18 per common share, a 20% increase, payable on
April 20, 2005, to shareholders of record on April 6, 2005. Additionally, the
Board expanded its share repurchase authorization by an additional $350
million, bringing the total... |
| | | 01/24/05 | New Blood Tests to Soon Replace Painful Bone Marrow Biopsies for Leukemia and Lymphoma Patients|
- Quest Diagnostics is granted an exclusive license from The University of
Texas M. D. Anderson Cancer Center to use proprietary technology based on
blood proteins -
TETERBORO, N.J., Jan. 24 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that The University of Texas M. D.
Anderson Cancer Center in Houston has granted the company... |
| | | 01/21/05 | Top Ranking by KLAS Enterprises for Electronic Patient Record Solution Awarded to Quest Diagnostics' MedPlus(TM) Subsidiary| TETERBORO, N.J., Jan. 21 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that its MedPlus healthcare
information technology subsidiary was recognized as the number one document
management and imaging (DMI) vendor in 2004 for its ChartMaxx(R)
enterprise-wide electronic record solution for hospitals, according to KLAS
Enterprises' "2004 TOP 20: Year-End Best in KLAS Awards." T... |
| | | 01/17/05 | Annals of Internal Medicine Studies Highlight Urgent Need for More Accurate and Patient-Friendly Colon Cancer Screening Tests| - InSure offers a more 'patient-friendly' solution for colorectal cancer screening and is included in the American Cancer Society's guidelines -
TETERBORO, N.J., Jan. 17 /PRNewswire-FirstCall/ -- Two studies published
in the Jan. 18 issue of Annals of Internal Medicine concluded that fecal
occult blood tests in which the physician takes a single sample during a
routine digital rectal exam (DRE) is not an acceptable way to screen for
colorectal cancer. In an accompanying editorial, Ha... |
| | | 01/10/05 | Quest Diagnostics to Speak at the 23rd Annual JPMorgan Healthcare Conference| TETERBORO, N.J., Jan 10, 2005 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Surya N. Mohapatra, Ph.D., Chairman
and Chief Executive Officer, is scheduled to speak at the 23rd Annual JPMorgan
Healthcare Conference on Tuesday, January 11, 2005, at the Westin St. Francis
in San Francisco, California. The Quest Diagnostics presentation is scheduled
to begin at 2:30 p... |
| | | 01/07/05 | Quest Diagnostics Gives $250,000 to American Red Cross to Aid Tsunami Relief Effort| TETERBORO, N.J., Jan. 7 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it has given $250,000 to the American
Red Cross International Response Fund to help in its effort to aid victims in
the aftermath of the tsunami affecting much of South Asia and Eastern Africa.
"As the tragedy continues to unfold, its impact is unfathomable," said
Surya N. Mohapatra, Ph.D., Chairman... |
| | | 12/16/04 | Quest Diagnostics Calls for Redemption All Outstanding 1-3/4% Contingent Convertible Debentures| TETERBORO, N.J., Dec. 16 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is calling for redemption on
January 18, 2005, all of its outstanding 1-3/4% contingent convertible
debentures (the "Debentures") due 2021. The aggregate principal amount
currently outstanding is approximately $250,000,000. The CUSIP number is
74834LAF7.
Holders of the Debentures redeemed for... |
| | | 12/15/04 | Surya N. Mohapatra, Ph.D., Becomes Chairman of Quest Diagnostics| - Gary M. Pfeiffer Elected to Board of Directors -
TETERBORO, N.J., Dec. 15 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it completed its previously-announced
leadership succession process, with Surya N. Mohapatra, Ph.D., assuming the
role of Chairman of the Board in addition to serving as President and Chief
Executive Officer. The change became effective after Ken... |
| | | 12/15/04 | Quest Diagnostics Repurchases 2.7 Million of Its Shares from GlaxoSmithKline; Intends to Call 1-3/4% Contingent Convertible Debentures| TETERBORO, N.J., Dec. 15 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it repurchased 2.7 million shares of
its common stock for approximately $254 million from GlaxoSmithKline plc
(NYSE: GSK). The share repurchase, which was separately authorized by the
Board of Directors and does not reduce the company's existing share repurchase
authorization, was financed primarily thro... |
| | | 12/14/04 | Quest Diagnostics Declares Quarterly Cash Dividend| TETERBORO, N.J., Dec. 14 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that its Board of Directors declared a
quarterly cash dividend on Quest Diagnostics common stock of $0.15 per share,
payable on January 26, 2005 to shareholders of record on January 11, 2005.
Quest Diagnostics Incorporated is the nation's leading provider of
diagnostic testing, information and services,... |
| | | 11/29/04 | Quest Diagnostics to Speak at the Merrill Lynch Health Services Investor Conference| TETERBORO, N.J., Nov. 29 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Robert A. Hagemann, Senior Vice
President and Chief Financial Officer, is scheduled to speak at the Merrill
Lynch Health Services Investor Conference on Tuesday, November 30, 2004, at
The Waldorf Astoria Hotel in New York City. The Quest Diagnostics
presentation is scheduled to begin at 8:45 a.m. Easter... |
| | | 11/05/04 | Quest Diagnostics to Speak at The CIBC World Markets Fifteenth Annual Healthcare Conference| TETERBORO, N.J., Nov. 5 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that David M. Zewe, Senior Vice President,
Diagnostic Testing Operations, is scheduled to speak at the CIBC World Markets
Fifteenth Annual Healthcare Conference on Monday, November 8, 2004, at The
Plaza Hotel in New York City. The Quest Diagnostics presentation is scheduled
to begin at 10:30 a.m. Eastern Time.... |
| | | 10/28/04 | Quest Diagnostics Receives Subpoenas Regarding Test Produced By Subsidiary| TETERBORO, N.J., Oct. 28 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it and its test kit manufacturing
subsidiary, Nichols Institute Diagnostics (NID), each received a subpoena from
the U.S. Attorney's office for the Eastern District of New York late Monday.
The subpoenas seek the production of various business records, including
documents related to NID's FDA-cleared tes... |
| | | 10/25/04 | Quest Diagnostics Reports Strong Financial Results in Third Quarter 2004| TETERBORO, N.J., Oct 25, 2004 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that for the third quarter ended September
30, 2004, net income increased to $130 million, or $1.26 per diluted share,
compared to $120 million, or $1.12 per diluted share, in 2003.
Third quarter revenues grew 5.6% over the prior-year level to $1.3
billion. Clinical testing volume, measure... |
| | | 10/21/04 | Surya N. Mohapatra, Ph.D. to Become Next Chairman of Quest Diagnostics| TETERBORO, N.J., Oct. 21 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that Surya N. Mohapatra, Ph.D., who
currently is President and Chief Executive Officer, will assume the additional
role of Chairman on December 14, 2004. As part of an orderly leadership
succession process, Kenneth W. Freeman will step down as Chairman of the Board
on that date.
"Surya Mohapatra ... |
| | | 10/15/04 | Quest Diagnostics' Care360 eMaxx(R) Physician Portal Now Offers Enhanced Electronic Prescribing Services With Online Access to Patients' Pharmacy Benefit Information|
-- See the Care360 eMaxx Physician Portal at Booth #2274 at the American
Academy of Family Physicians Scientific Assembly in Orlando, Florida,
October 14-17, 2004 -
TETERBORO, N.J., Oct. 15 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX) announced today that its Care360 eMaxx physician
portal now offers enhanced electronic prescribing services with online access
to patients' pharmacy benefit information. The patient-centri... |
| | | 09/28/04 | Quest Diagnostics Honored as One of Nation's Top 100 Business Technology Innovators By InformationWeek| TETERBORO, N.J., Sept. 28 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, has been honored as one of the nation's Top 100
Innovators in the prestigious InformationWeek 500 ranking, published in the
September 20 edition of CMP Media's InformationWeek magazine. Quest
Diagnostics ranked #87, up from #149 in 2003.
"We are pleased to be one of InformationWeek's top innovators and to be
in... |
| | | 09/27/04 | Quest Diagnostics Joins Dow Jones Sustainability World Index| TETERBORO, N.J., Sep 27, 2004 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it has been added to the Dow Jones
Sustainability World Index (DJSI World), effective September 20.
The Index contains more than 300 companies identified as "sustainability
leaders," ranked according to objective benchmarks linked to financial,
environmental and social criteria. The D... |
| | | 09/27/04 | Quest Diagnostics to Speak at UBS Global Life Sciences Conference| TETERBORO, N.J., Sept. 27 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Robert A. Hagemann, Senior Vice
President and Chief Financial Officer, is scheduled to speak at the UBS Global
Life Sciences Conference on Tuesday, September 28, 2004, at The Grand Hyatt
Hotel in New York City. The Quest Diagnostics presentation is scheduled to
begin at 3:00 p.m. Eastern Time.
Th... |
| | | 09/20/04 | Quest Diagnostics to Offer New Test to Measure Circulating Tumor Cells in Patients With Metastatic Breast Cancer| TETERBORO, N.J., Sept. 20 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that it has signed an agreement with
Veridex, LLC, a Johnson & Johnson (NYSE: JNJ) company, to be the only national
commercial reference laboratory to offer a test using Veridex's CellSearch(TM)
Circulating Tumor Cell Kit, a new cancer diagnostic technology that identifies
and counts circulating tumor ... |
| | | 09/17/04 | Quest Diagnostics to Speak at The Banc of America Securities 34th Annual Investment Conference| TETERBORO, N.J., Sept. 17 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Surya N. Mohapatra, Ph.D., President
and Chief Executive Officer, is scheduled to speak at the Banc of America
Securities 34th Annual Investment Conference on Monday, September 20, 2004, at
The Ritz-Carlton Hotel in San Francisco, California. The Quest Diagnostics
presentation is scheduled to begin at 1... |
| | | 09/07/04 | Quest Diagnostics to Speak at The Thomas Weisel Partners Tailwinds 2004 Conference| TETERBORO, N.J., Sept. 7 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Robert A. Hagemann, Senior Vice
President and Chief Financial Officer, is scheduled to speak at the Thomas
Weisel Partners Tailwinds Conference on Wednesday, September 8, 2004, at The
Four Seasons Hotel in Boston, Massachusetts. The Quest Diagnostics
presentation is scheduled to begin at 8:00 a.m. Easte... |
| | | 08/23/04 | New Services on Quest Diagnostics' eMaxx(R) Web Portal to Help Physicians Participate in Pay-for-Performance Programs and Move Physician Practices Toward Clinical Integration| - Quest Diagnostics and The IPA Association of America to Jointly Promote
eMaxx to 300,000 IPA-Affiliated Doctors -
TETERBORO, N.J. and OAKLAND, Calif., Aug. 23 /PRNewswire-FirstCall/ --
Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, announced it will begin to offer
a suite of new services for its eMaxx Internet-based portal to help physicians
participate in government-sponsored and private... |
| | | 07/28/04 | NCQA Receives Three-Year Grant From Quest Diagnostics|
Grant Supports Health Care Quality Advancements
WASHINGTON – The National Committee for Quality Assurance (NCQA) announced today that it received a three-year grant from Quest Diagnostics Incorporated, a national provider of diagnostic testing, information and services. This grant supports NCQA's mission to improve the quality of health care by helping NCQA expand efforts to enhance quality evaluation at the provider level and to implement and evaluate new HEDIS® (Health Plan Employ... |
| | | 07/22/04 | Quest Diagnostics Reports Strong Financial Results in Second Quarter 2004| TETERBORO, N.J., July 22 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that for the second quarter ended June 30,
2004, net income increased to $135 million, or $1.28 per diluted share, before
$13.2 million in special, pre-tax charges, or $0.08 per share, related to the
recently completed CEO succession process and the company's debt refinancing,
both of which had been previousl... |
| | | 07/22/04 | Quest Diagnostics Increases Share Repurchase Authority by $300 Million and Declares Quarterly Cash Dividend| TETERBORO, N.J., July 22 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that its Board of Directors increased the
company's share repurchase authorization by an additional $300 million. In
addition, the Board declared a quarterly cash dividend on Quest Diagnostics
common stock of $0.15 per share, payable on October 22, 2004 to shareholders
of record on October 8, 2004.
Thr... |
| | | 07/22/04 | Increased Use of Amphetamines Linked to Rising Workplace Drug Use, According to Quest Diagnostics' 2003 Drug Testing Index| - Opiate Use Increases Noticeably - TETERBORO, N.J., Jul 22, 2004 /PRNewswire-FirstCall via COMTEX/ -- Increased use of
amphetamines among general U.S. workforce employees was linked to rising
workplace drug use during 2003, according to the semi-annual Drug Testing
Index(R), released today by Quest Diagnostics Incorporated (NYSE: DGX), the
leading provider of employer drug testing services in the United States.
Overall, the drug positivity rate increased to 4.5% in 2003 from 4.4% a
y... |
| | | 07/14/04 | Top Ranking By KLAS Enterprises For Electronic Patient Record Solution Awarded To Quest Diagnostics' MedPlus(TM) Subsidiary| TETERBORO, N.J., July 14 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that its MedPlus healthcare
information technology subsidiary was recognized as the number one document
management and imaging (DMI) vendor for its ChartMaxx(R) enterprise-wide
electronic patient record (EPR) solution for hospitals. The ranking was
released by KLAS Enterprises in its "Top 20: Mid-Year... |
| | | 06/23/04 | Quest Diagnostics to Speak at The Wachovia Securities' Fourteenth Annual Nantucket Conference| TETERBORO, N.J., Jun 23, 2004 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Robert A. Hagemann, Senior Vice
President, Chief Financial Officer, is scheduled to speak at the Wachovia
Securities' Fourteenth Annual Nantucket Conference on, June 24, 2004, at
Harbor House Village, in Nantucket, Massachusetts. The Quest Diagnostics
presentation is scheduled to begin at... |
| | | 06/15/04 | Quest Diagnostics to Speak at the Thomas Weisel Partners Growth Forum 6.0| TETERBORO, N.J., June 15 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Joan E. Miller, Ph.D., Vice
President, Hospital Business, and Laure E. Park, Vice President, Investor
Relations, are scheduled to speak at the Thomas Weisel Partners Growth Forum
6.0 on Wednesday, June 16, 2004, at The Montage Resort, in Laguna Beach,
California. The Quest Diagnostics presentation is sch... |
| | | 06/09/04 | Quest Diagnostics Enters Into an Agreement with Express Scripts to Provide Physicians with Enhanced ePrescribing Capabilities| TETERBORO, N.J., June 9 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic
laboratory testing, information and services, today announced that it has
entered into an agreement with Express Scripts (Nasdaq: ESRX), one of the
largest pharmacy benefit management companies in North America, to provide
physicians with online access to Express Scripts' pharmacy benefit management
services. The electronic prescribing, or ePrescribing ... |
| | | 06/08/04 | Quest Diagnostics to Speak at the Goldman Sachs Twenty-Fifth Annual Global Healthcare Conference| TETERBORO, N.J., June 8 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Surya N. Mohapatra, Ph.D., President
and Chief Executive Officer, is scheduled to speak at the Goldman Sachs
Twenty-Fifth Annual Global Healthcare Conference on Wednesday, June 9, 2004,
at The Ritz Carlton Laguna Niguel, in Dana Point, California. The Quest
Diagnostics presentation is scheduled to begin a... |
| | | 05/18/04 | Diagnostics Leaders Collaborate to Help Physicians Better Differentiate Allergy-Like Symptoms| TETERBORO, N.J., May 18 /PRNewswire-FirstCall/ -- Primary care physicians
are learning how they can better manage patients with allergy-like symptoms by
obtaining objective evidence to differentiate those who are allergic from
those who are not, thanks to a nationwide educational collaboration between
Quest Diagnostics (NYSE: DGX) and Pharmacia Diagnostics AB. The
collaboration's central message is that expanded use of blood testing for
allergy at the primary care level is the key to impr... |
| | | 05/18/04 | Quest Diagnostics to Speak at the Banc of America Securities Health Care Conference| TETERBORO, N.J., May 18 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Surya N. Mohapatra, Ph.D., President
and Chief Executive Officer, is scheduled to speak at the Banc of America
Securities Health Care Conference on Wednesday, May 19, 2004, at The Four
Seasons Hotel in Las Vegas, Nevada. The Quest Diagnostics presentation is
scheduled to begin at 2:20 p.m. Eastern Time.
... |
| | | 05/06/04 | Quest Diagnostics Signs Multi-Year Agreement with TriPath Imaging To Launch SurePath(TM) Liquid-Based Pap Test Nationally| TETERBORO, N.J. and BURLINGTON, N.C., May 6 /PRNewswire-FirstCall/ --
Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, and TriPath Imaging, Inc.
(Nasdaq: TPTH), a leading provider of innovative solutions to improve the
clinical management of cancer, announced today an agreement in which Quest
Diagnostics will launch TriPath Imaging's SurePath(TM) liquid-based Pap test
for cervical cancer screening to its physician cu... |
| | | 05/05/04 | Quest Diagnostics to Speak at The Morgan Stanley Second Annual Global Healthcare Unplugged Conference| TETERBORO, N.J., May 5, 2004 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that David M. Zewe, Senior Vice President,
Diagnostic Testing Operations, and Laure E. Park, Vice President, Investor
Relations, are scheduled to speak at the Morgan Stanley Second Annual Global
Healthcare Unplugged Conference on Thursday, May 6, 2004, at The Mandarin
Oriental Miami, in Miami, ... |
| | | 05/04/04 | Surya N. Mohapatra, Ph.D., Appointed CEO of Quest Diagnostics| - Kenneth W. Freeman to Continue as Chairman of the Board -
- John C. Baldwin, M.D., Elected to Board of Directors -
TETERBORO, N.J., May 4 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that Surya N. Mohapatra, Ph.D., was
appointed President and Chief Executive Officer, completing the CEO succession
plan announced in November, 2003. Dr. Mohapatra succee... |
| | | 05/04/04 | Quest Diagnostics Declares Quarterly Cash Dividend| TETERBORO, N.J., May 4 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that its Board of Directors has
declared a quarterly cash dividend on its common stock of $0.15 per share,
payable on July 21, 2004 to shareholders of record on July 7, 2004.
Quest Diagnostics Incorporated is the nation's leading provider of
diagnostic testing, information and services, providing in... |
| | | 05/04/04 | Quest Diagnostics Offers Gene-Based Test for Congenital Adrenal Hyperplasia|
- Visit Quest Diagnostics at the Pediatric Academic Societies' Meeting
at the Moscone Convention Center in San Francisco (May 1-4, 2004) at Booth #930
-
TETERBORO, N.J., May 4 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it has developed and is now offering
a gene-based blood test to detect genetic mutations associated with congenital
adrenal hyperpla... |
| | | 04/22/04 | Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2004| TETERBORO, N.J., April 22 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that for the first quarter ended March 31,
2004, net income increased to $116 million from $88 million in the first
quarter of 2003. Earnings per diluted share increased 28% to $1.10 from $0.86
in 2003.
First quarter revenues grew 14.9% over the prior-year level to
$1.3 billion and reflect the acquisi... |
| | | 04/22/04 | Quest Diagnostics to Complete CEO Transition on May 4, 2004|
- Surya N. Mohapatra, Ph.D., to Become Chief Executive Officer -
- Kenneth W. Freeman to Continue as Chairman Of The Board -
TETERBORO, N.J., April 22 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that Surya N. Mohapatra, Ph.D., will
be appointed President and Chief Executive Officer on May 4, 2004, the date of
the Annual Meeting of Stockholders... |
| | | 04/13/04 | John C. Baldwin, M.D., Nominated for Election to Quest Diagnostics Board of Directors| TETERBORO, N.J., April 13 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the leading provider of diagnostic testing,
information and services, announced today that its Board of Directors has
nominated John C. Baldwin, M.D., for election as a Director at its 2004 Annual
Meeting of Stockholders.
Separately, the company announced that two current Directors, Kenneth D.
Brody and Mary A. Cirillo, each of whose terms expires at the 2004 annual
meeting, will retire f... |
| | | 03/15/04 | Quest Diagnostics and Medco Health Solutions Launch Initiative to Increase Use of ePrescribing| Agreement Provides Physicians with Access to ePrescribing Technology FRANKLIN LAKES, N.J. and TETERBORO, N.J., Mar 15, 2004 /PRNewswire-FirstCall via COMTEX/ -- Medco Health Solutions (NYSE: MHS), one of the
nation's leading providers of pharmacy benefit management services, and Quest
Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, today announced a new initiative
to provide physicians with online access to pharmacy benefi... |
| | | 02/25/04 | Quest Diagnostics' Healthcare Information Technology Subsidiary, MedPlus, Enters Into an Agreement with SureScripts to Provide Physicians With Electronic Prescribing Capabilities| TETERBORO, N.J., and ALEXANDRIA, Va., Feb. 25 /PRNewswire-FirstCall/ --
Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic laboratory testing, information and services, announced today that
the company's healthcare information technology subsidiary, MedPlus, has
entered into an agreement with SureScripts to provide physicians with
electronic prescribing capabilities.
SureScripts is at the forefront of a growing movement to harness
technology to i... |
| | | 02/23/04 | Quest Diagnostics to Speak at Wachovia Securities Cancer Diagnostics Conference| TETERBORO, N.J., Feb. 23 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Joyce G. Schwartz, M.D., Vice
President and Chief Laboratory Officer, and Richard A. Bender, M.D., Medical
Director, Hematology/Oncology, are scheduled to speak at the Wachovia
Securities Cancer Diagnostics Conference on Tuesday, February 24, 2004, at The
New York Palace Hotel, in New York City. The Ques... |
| | | 02/19/04 | Quest Diagnostics Declares Quarterly Cash Dividend| TETERBORO, N.J., Feb. 19 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that its Board of Directors has
declared a quarterly cash dividend on its common stock of $0.15 per share,
payable on April 21, 2004 to shareholders of record on April 7, 2004.
Quest Diagnostics Incorporated is the nation's leading provider of
diagnostic testing, information and services, providin... |
| | | 02/03/04 | Quest Diagnostics to Speak at UBS Global Healthcare Services Conference| TETERBORO, N.J., Feb. 3 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Robert A. Hagemann, Senior Vice
President and Chief Financial Officer, is scheduled to speak at the UBS Global
Healthcare Services Conference on Tuesday, February 3, 2004, at The Plaza
Hotel in New York City. The Quest Diagnostics presentation is scheduled to
begin at 9:30 a.m. Eastern Time.
The pr... |
| | | 01/27/04 | Quest Diagnostics to Speak at U.S. Bancorp Piper Jaffray Health Care Conference| TETERBORO, N.J., Jan. 27 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Surya N. Mohapatra, Ph.D., President
and Chief Operating Officer, is scheduled to speak at the U.S. Bancorp Piper
Jaffray Health Care Conference on Thursday, January 29, 2004, at The Pierre
Hotel in New York City. The Quest Diagnostics presentation is scheduled to
begin at 11:30 a.m. Eastern Time.
... |
| | | 01/27/04 | Quest Diagnostics Announces Strong Revenue and Earnings Growth For Fourth Quarter and Full Year 2003| TETERBORO, N.J., Jan. 27 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that for the fourth quarter ended
December 31, 2003, net income increased to $108 million from $82 million in
2002. Earnings per diluted share increased 24% to $1.02 from $0.82 in 2002.
Fourth quarter revenues increased 16.5% over the prior year level to
$1.2 billion and reflect the acquisition of Unila... |
| | | 01/09/04 | Quest Diagnostics to Speak at the 22nd Annual JPMorgan Healthcare Conference| TETERBORO, N.J., Jan. 9 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Surya N. Mohapatra, Ph.D., President
and Chief Operating Officer, is scheduled to speak at the 22nd Annual JPMorgan
Healthcare Conference on Monday, January 12, 2004, at The Westin St. Francis
Hotel in San Francisco, California. The Quest Diagnostics presentation is
scheduled to begin at 11:00 a.m. Easte... |
| | | 12/02/03 | Quest Diagnostics to Speak at Merrill Lynch Health Services Investor Conference| TETERBORO, N.J., Dec. 2 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Surya N. Mohapatra, Ph.D., President
and Chief Operating Officer, is scheduled to speak at the Merrill Lynch Health
Services Investor Conference on Wednesday, December 3, 2003, at The Waldorf
Astoria in New York City. The Quest Diagnostics presentation is scheduled to
begin at 9:15 a.m. Eastern Time.
... |
| | | 11/10/03 | Quest Diagnostics Announces Succession Plan; Surya N. Mohapatra, Ph.D., to Succeed Kenneth W. Freeman as CEO in 2004| - Freeman to Remain Chairman of the Board of Directors During Smooth
Transition Process -
TETERBORO, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that its Board of Directors has
begun implementing an orderly succession plan in which Surya N. Mohapatra,
Ph.D., will succeed Kenneth W. Freeman as Chief Executive Officer by th... |
| | | 11/07/03 | Quest Diagnostics to Speak at the CIBC World Markets 14th Annual Health Care Conference| TETERBORO, N.J., Nov. 7 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Surya N. Mohapatra, Ph.D., President
and Chief Operating Officer, is scheduled to speak at the CIBC World Markets
14th Annual Health Care Conference on Monday, November 10, 2003, at The Plaza
Hotel in New York City. The Quest Diagnostics presentation is scheduled to
begin at 11:00 a.m. Eastern Time.
... |
| | | 11/05/03 | Drug Use Climbed in the U.S. Workforce in the First Half of 2003, Driven by Continued Growth in Use of Amphetamines, According to Quest Diagnostics' Drug Testing Index| TETERBORO, N.J., Nov. 5 /PRNewswire-FirstCall/- Drug use in the general
U.S. workforce climbed in the first half of 2003, driven by continued growth
in the use of amphetamines, according to the semi-annual Drug Testing Index
released today by Quest Diagnostics Incorporated (NYSE: DGX), the leading
provider of employer drug testing services in the United States.
The Drug Testing Index summarizes the results of workplace drug tests
performed by Quest Diagnostics between January and Jun... |
| | | 10/21/03 | Quest Diagnostics Earnings Per Share Increased 29% in Third Quarter 2003| - Earnings Per Share Expected to Grow 12-15% in 2004 -
TETERBORO, N.J., Oct. 21 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that for the third quarter ended
September 30, 2003, net income increased to $120 million from $87 million in
the third quarter of 2002. Earnings per diluted share increased 29% to
$1.12 from $0.87 in 2002. Separately, the company also announced ... |
| | | 10/21/03 | Quest Diagnostics Initiates Quarterly Cash Dividend And Increases Share Repurchase Authorization by $300 Million| TETERBORO, N.J., Oct. 21 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that its Board of Directors has approved
the payment of a quarterly cash dividend of $0.15 per share and increased the
company's share repurchase authorization by an additional $300 million. The
initial quarterly dividend will be payable on January 23, 2004 to shareholders
of record on January 8, 2004.
... |
| | | 10/16/03 | Quest Diagnostics Appoints Mervyn A. Sahud, M.D., to Lead Coagulation Laboratory Program| TETERBORO, N.J., Oct. 16 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, today announced that it has appointed Mervyn A.
Sahud, M.D., F.A.C.P, as Medical Director for Coagulation.
Dr. Sahud is responsible for leading Quest Diagnostics' national
coagulation laboratory program and enhancing the coagulation testing services
provided to healthcare specialists seeking guidance on test inte... |
| | | 10/08/03 | Delbert Fisher, M.D., Vice President for Science and Innovation At Quest Diagnostics, Is Honored by The National Institute Of Child Health and Human Development (NICHD)| TETERBORO, N.J., Oct. 8 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Delbert A. Fisher, M.D., Vice
President of Science and Innovation, was honored by The National Institute of
Child Health and Human Development (NICHD) for his outstanding scientific
contributions to the creation of a screening test for congenital
hypothyroidism in newborns.
Dr. Fisher was one of 15... |
| | | 09/30/03 | Quest Diagnostics Appoints Renowned Cancer Scientist, Maher Albitar, M.D., Medical Director for Hematopathology| TETERBORO, N.J., Sept. 30 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, today announced the appointment of Maher Albitar,
M.D., a renowned cancer scientist, to Medical Director for Hematopathology.
Previously, Dr. Albitar was a tenured professor at The University of Texas
M. D. Anderson Cancer Center in Houston, where he served as Chief of the
Leukemia Section in the Department of H... |
| | | 09/19/03 | Quest Diagnostics to Speak at UBS Global Life Sciences Conference| TETERBORO, N.J., Sept. 19 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Surya N. Mohapatra, President and
Chief Operating Officer, is scheduled to speak at the UBS Global Life Sciences
Conference on Monday, September 22, 2003, at The Plaza Hotel in New York City.
The Quest Diagnostics presentation is scheduled to begin at 10:30 a.m. Eastern
Time.
The presentation wil... |
| | | 09/15/03 | Quest Diagnostics to Speak at The Banc of America Securities 33rd Annual Investment Conference| TETERBORO, N.J., Sept. 15 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Robert A. Hagemann, Vice President
and Chief Financial Officer, is scheduled to speak at the Banc of America
Securities 33rd Annual Investment Conference on Tuesday, September 16, 2003,
at the Ritz-Carlton Hotel in San Francisco, California. The Quest Diagnostics
presentation is scheduled to begin at 8... |
| | | 09/03/03 | Quest Diagnostics to Speak at the Thomas Weisel Partners Healthcare Tailwinds 2003 Conference| TETERBORO, N.J., Sept. 3 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Robert A. Hagemann, Vice President
and Chief Financial Officer, is scheduled to speak at the Thomas Weisel
Partners Healthcare Tailwinds 2003 Conference on Thursday, September 4, 2003,
at the Four Seasons Hotel in Boston, Massachusetts. The Quest Diagnostics
presentation is scheduled to begin at 8:00 a.... |
| | | 08/07/03 | Quest Diagnostics Offers InSure(TM) Colorectal Cancer Screening Test To Help Physicians Identify Cancer at an Early Stage| - Test is Easy for Patients to Use, Non-Invasive, Sensitive and Specific -
TETERBORO, N.J., Aug. 7 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), a leading provider of cancer screening and
diagnostic testing, information and services, today announced that it has
begun to offer InSure(TM), an FDA-cleared fecal immunochemical test to detect
the presence of blood in stool samples. The test is intended to help
physicians screen for colorectal cancer at an early s... |
| | | 08/04/03 | Quest Diagnostics Sponsors Distribution of the National Comprehensive Cancer Network's CD-ROM on Cancer Testing Guidelines for Non-Cancer Specialists| TETERBORO, N.J., Aug 4, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics
Incorporated (NYSE: DGX), a leading provider of cancer screening and
diagnostic testing, today announced its sponsorship to support the
distribution of the National Comprehensive Cancer Network's (NCCN) new CD-ROM
entitled Cancer Testing: Work up, Staging, and Follow-up within the Complete
Library of NCCN Clinical Practice Guidelines in Oncology. The guidelines for
cancer testing are intended to acquaint ... |
| | | 07/24/03 | Quest Diagnostics Expands Heart Disease Test Offerings With Lp-PLA2 Test For Cardiovascular Risk Assessment| TETERBORO, N.J., July 24 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of gene-based medical
testing, announced that it has begun to offer a test to enable physicians to
detect a new risk factor for cardiovascular disease by measuring levels of the
enzyme Lp-PLA2 (lipoprotein-associated phospholipase A2). Elevated levels of
Lp-PLA2 indicate that a patient is at an increased risk of suffering a
cardiovascular event, such as a heart atta... |
| | | 07/22/03 | Quest Diagnostics Earnings Per Share Increased 29% In Second Quarter 2003| TETERBORO, N.J., July 22 /PRNewswire-FirstCall/ --
Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, announced that for the second
quarter ended June 30, 2003, net income increased to $120.4 million from
$87.2 million in the second quarter of 2002. Earnings per diluted share
increased 29% to $1.12 from $0.87 in 2002.
Second quarter revenues increased 14% over the prior year level to
$1.2 billion and reflect the acq... |
| | | 06/25/03 | Quest Diagnostics to Speak at the 2003 Wachovia Securities Nantucket Equity Conference| TETERBORO, N.J., June 25 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Robert A. Hagemann, Vice President
and Chief Financial Officer is scheduled to speak at the 2003 Wachovia
Securities Nantucket Equity Conference on Thursday, June 26, 2003, at The
Harbor House Village in Nantucket, Massachusetts. The Quest Diagnostics
presentation is scheduled to begin at 10:45 a.m. Eas... |
| | | 06/17/03 | Quest Diagnostics to Speak at the Thomas Weisel Partners Growth Forum 5.0| TETERBORO, N.J., June 17 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Kenneth W. Freeman, Chairman and
Chief Executive Officer, is scheduled to speak at the Thomas Weisel Partners
Growth Forum 5.0 on Tuesday, June 17, 2003, at The Bacara Resort in Santa
Barbara, California. The Quest Diagnostics presentation is scheduled to begin
at 11:40 a.m. Pacific Time.
The pres... |
| | | 06/09/03 | Quest Diagnostics to Speak at the Goldman Sachs Twenty-Fourth Annual Global Healthcare Conference| TETERBORO, N.J., June 9 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Surya N. Mohapatra, President and
Chief Operating Officer, is scheduled to speak at the Goldman Sachs
Twenty-Fourth Annual Global Healthcare Conference on Tuesday, June 10, 2003,
at The Ritz-Carlton Laguna Niguel Hotel in Dana Point, California. The Quest
Diagnostics presentation is scheduled to begin at ... |
| | | 06/05/03 | Quest Diagnostics and Stop & Shop Partner to Offer QuesTest(TM) Consumer Health Testing Services in Connecticut| TETERBORO, N.J. and QUINCY, Mass., Jun 5, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX) and the Stop & Shop Supermarket Company
today launched QuesTest(TM) consumer health testing services in more than 60
Stop & Shop Pharmacies throughout Connecticut. QuesTest(TM) health testing is
a revolutionary concept in consumer-driven health care that now offers Stop &
Shop customers an important new way to take charge of their health through
commonly ordered sc... |
| | | 05/27/03 | Amphetamine Use Increases In the General U.S. Workforce, According to Quest Diagnostics' 2002 Drug Testing Index| - Overall Workplace Drug Use Declines to 14-year Low in 2002 -
TETERBORO, N.J., May 27 /PRNewswire-FirstCall/ -- The incidence of
positive drug test results attributed to amphetamine use increased
substantially among general U.S. workforce employees over the last five years
during a time when amphetamines became more widely accessible,(1) according to
the annual Drug Testing Index(R), released today by Quest Diagnostics
Incorporated (NYSE: DGX), the leading provider of employer drug... |
| | | 05/19/03 | Quest Diagnostics and Enterix Enter Into an Agreement to Offer InSure(TM), A Patient-Friendly Immunochemical Test for Colorectal Cancer Screening| TETERBORO, N.J., and FALMOUTH, Maine, May 19 /PRNewswire-FirstCall/ --
Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, and Enterix Inc., a privately
held colorectal cancer screening company, today announced that they have
entered into an agreement to offer InSure(TM), Enterix' proprietary,
FDA-cleared test to detect human hemoglobin in fecal samples. Terms of the
agreement were not disclosed.
Studies show th... |
| | | 05/13/03 | Quest Diagnostics Announces Share Repurchase Plan| TETERBORO, N.J., May 13, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics
Incorporated (NYSE: DGX) today announced that its Board of Directors has
authorized an expenditure of up to $300 million to repurchase shares of its
common stock. The company had approximately 105 million shares outstanding as
of March 31, 2003.
Under the repurchase authority, management has the discretion to
repurchase stock in the open market or in privately negotiated transactions.
The program is p... |
| | | 05/06/03 | Quest Diagnostics Presentation at Deutsche Bank Securities Healthcare Conference Available on Internet| TETERBORO, N.J., May 6 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that an archived webcast of the
presentation by its management at the Deutsche Bank Securities Healthcare
Conference earlier today in Baltimore, Maryland, is available on the Quest
Diagnostics website: http://www.questdiagnostics.com through Friday, June 13,
2003.
The presentation by Robert A. Hagemann, ... |
| | | 04/22/03 | Quest Diagnostics Reports Strong Earnings Per Share Growth In First Quarter 2003| TETERBORO, N.J., April 22 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that for the first quarter ended March 31,
2003, net income increased to $88.0 million from $66.7 million in the first
quarter of 2002. Earnings per diluted share increased 28% to $0.86 from $0.67
in 2002. The acquisition of Unilab Corporation, which was completed on
February 28, 2003, contributed approximat... |
| | | 04/17/03 | Quest Diagnostics and Thermo Electron Launch First Commercial Gene-based Medical Test Using a Biochip| Collaboration to Produce Additional Biochips for Various Diseases
TETERBORO, N.J. and WALTHAM, Mass., April 17 /PRNewswire-FirstCall/ --
Quest Diagnostics Incorporated (NYSE: DGX) and Thermo Electron Corporation
(NYSE: TMO) announced that their collaboration has resulted in an automated,
biochip-based laboratory test for the detection of cystic fibrosis (CF) gene
mutations during prenatal screening. The new biochip array can be used for
multiplex testing, which allows multiple DNA ... |
| | | 04/09/03 | Quest Diagnostics to Speak at Wachovia Securities Cancer Diagnostics Conference| TETERBORO, N.J., April 9 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Lucia Quinn, Senior Vice President,
Business Development, and Richard Bender, M.D., Medical Director,
Hematology/Oncology, are scheduled to speak at the Wachovia Securities Cancer
Diagnostics Conference on Thursday, April 10, 2003, at the Swissotel, in New
York City. The Quest Diagnostics presentation is... |
| | | 03/25/03 | Quest Diagnostics Appoints Robert E. Peters Vice President, Sales and Marketing|
TETERBORO, N.J., Mar 25, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, today announced that Robert E.
Peters has been appointed Vice President, Sales and Marketing.
Mr. Peters will be responsible for leading Sales and Marketing initiatives
driving overall profitable growth through ensuring a comprehensive focus on
meeting the needs of customers.
In 2002, Mr. Peter... |
| | | 03/24/03 | Quest Diagnostics to Speak at the Banc of America Securities Healthcare Conference|
TETERBORO, N.J., Mar 24, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, announced that Robert A. Hagemann,
Vice President and Chief Financial Officer, is scheduled to speak at the Banc of
America Securities Healthcare Conference on Tuesday, March 25, 2003, at the Four
Seasons Hotel in Las Vegas, Nevada. The Quest Diagnostics presentation is
scheduled to begin at 12:45 p.m... |
| | | 03/17/03 | Quest Diagnostics to Speak At the SG Cowen 23rd Annual Health Care Conference|
TETERBORO, N.J., Mar 17, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, announced that Kenneth W. Freeman,
Chairman and Chief Executive Officer, is scheduled to speak at the SG Cowen 23rd
Annual Health Care Conference on Tuesday, March 18, 2003, at the Marriott Copley
Place, in Boston, Massachusetts. The Quest Diagnostics presentations are
scheduled for 8:00 a.m. to 8:45 ... |
| | | 03/07/03 | Quest Diagnostics Successfully Completes Unilab Debt Tender Offer|
TETERBORO, N.J., Mar 7, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX) announced that it successfully completed
the cash tender offer for all of the outstanding $100.8 million 12-3/4% Senior
Subordinated Notes due 2009 of Unilab Corporation (Nasdaq: ULAB). The cash
tender offer expired, as scheduled, at 12:00 midnight, New York City time, on
Thursday, March 6, 2003, and was settled today.
As of the expiration date, 100% of the $100.8 million 12-3/... |
| | | 03/06/03 | Quest Diagnostics to Speak at Wachovia Securities Ninth Annual Convertible Securities Conference|
TETERBORO, N.J., Mar 6, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, announced that Laure E. Park, Vice
President, Investor Relations, and Joseph P. Manory, Vice President and
Treasurer, are scheduled to speak at the Wachovia Securities Ninth Annual
Convertible Securities Conference on Friday, March 7, 2003, at the Mandarin
Oriental-Miami, in Miami, Florida. The Quest D... |
| | | 03/05/03 | Quest Diagnostics Sets Purchase Price in Tender Offer and Consent Solicitation for Unilab 12 3/4% Senior Subordinated Notes Due 2009|
TETERBORO, N.J., Mar 5, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX) announced today the tender offer
consideration and the total consideration to be paid for notes validly tendered
in its cash tender offer for all of the outstanding $100.8 million 12 3/4%
Senior Subordinated Notes due 2009 of Unilab Corporation (Nasdaq: ULAB). The
tender offer is subject to the terms and conditions set forth in the Offer to
Purchase and Consent Solicitation Statem... |
| | | 03/04/03 | Quest Diagnostics Announces Final Results of Unilab Exchange Offer|
TETERBORO, N.J., Mar 4, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, announced today the final
calculations regarding the consideration to be paid to Unilab shareholders who
elected cash in the previously announced exchange offer.
In the exchange offer, approximately 34.7 million shares were tendered for cash.
The cash election feature of the exchange offer was over-... |
| | | 03/03/03 | Quest Diagnostics Announces Preliminary Results of Unilab Exchange Offer|
TETERBORO, N.J., Mar 3, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, announced today the preliminary
calculations regarding the consideration to be paid to Unilab shareholders who
had elected cash in the previously announced exchange offer. The deadline for
delivering Unilab shares tendered pursuant to notices of guaranteed delivery
expired at 5:00 p.m. on Friday, Febru... |
| | | 02/27/03 | Quest Diagnostics Announces Receipt of Requisite Consents in Cash Tender For Unilab 12 3/4% Senior Subordinated Notes Due 2009|
TETERBORO, N.J., Feb. 27 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX) announced today that, as of 5:00 p.m., New York City
time, on February 26, 2003 (the consent date), it had received the requisite
consents from the holders of the 12 3/4% Senior Subordinated Notes due 2009 of
Unilab Corporation (Nasdaq: ULAB) to certain amendments to the indenture under
which the notes were issued. Specifically, Quest Diagnostics received
consents from 100% of holde... |
| | | 02/26/03 | Quest Diagnostics Acquires Unilab|
TETERBORO, N.J., Feb 26, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, announced today it has acquired
Unilab Corporation (Nasdaq: ULAB) by accepting for payment all shares of Unilab
common stock that were tendered pursuant to the previously announced cash
election exchange offer. As of 12:00 midnight, New York City time, on February
25, 2003, more than 36 million shares... |
| | | 02/25/03 | Quest Diagnostics Updates 2003 Guidance|
TETERBORO, N.J., Feb 25, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, today announced updated guidance
for its 2003 financial performance to reflect the acquisition of Unilab
Corporation (Nasdaq: ULAB) and the impact of severe winter weather. On
Wednesday, February 26, the company expects to accept for payment all shares
validly tendered in the exchange offer for Unilab... |
| | | 02/21/03 | Quest Diagnostics Receives FTC Clearance to Proceed With Acquisition of Unilab|
TETERBORO, N.J., Feb 21, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX) confirmed that it has received clearance
from the Federal Trade Commission (FTC) to proceed with its previously announced
acquisition of Unilab Corporation (Nasdaq: ULAB). The cash election exchange
offer will expire at 12:00 midnight, New York City time, on Tuesday, February
25, 2003. If all the conditions to the exchange offer are satisfied on February
26, 2003, Quest Diagnosti... |
| | | 02/21/03 | Quest Diagnostics Extends Consent Date for Cash Tender Offer to Purchase All Outstanding Unilab 12 3/4% Senior Subordinated Notes|
TETERBORO, N.J., Feb 21, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX) announced that it has extended the consent
date for its previously announced cash tender offer to purchase all outstanding
12 3/4% Senior Subordinated Notes Due 2009 of Unilab Corporation. The consent
date was extended by three business days and will now expire at 5:00 p.m., New
York City time, on Wednesday, February 26, 2003, unless extended. The expiration
date of the tender of... |
| | | 02/19/03 | Quest Diagnostics Extends Exchange Offer for Shares of Unilab|
TETERBORO, N.J., Feb 19, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX) announced that it has extended the
expiration date for its previously announced cash election exchange offer for
all outstanding shares of Unilab Corporation common stock. The offer was
extended by five business days and will now expire at 12:00 midnight, New York
City time, on Tuesday, February 25, 2003, unless extended.
The acquisition of Unilab is subject to approval by the... |
| | | 02/13/03 | James F. Flaherty III Elected to Quest Diagnostics Board of Directors|
TETERBORO, N.J., Feb 13, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the leading provider of diagnostic
testing, information and services, announced today that its Board of Directors
has elected James F. ("Jay") Flaherty III to serve as a Director, expanding the
Board to 12 members.
Mr. Flaherty, 45, is the President and Chief Operating Officer and a member of
the Board of Directors of Health Care Property Investors (NYSE: HCP), a
self-admini... |
| | | 02/11/03 | Quest Diagnostics Extends Exchange Offer for Shares of Unilab|
TETERBORO, N.J., Feb 11, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX) announced that it has extended the
expiration date for its previously announced cash election exchange offer for
all outstanding shares of Unilab Corporation common stock. The offer was
extended by five business days and will now expire at 12:00 midnight, New York
City time, on Tuesday, February 18, 2003, unless extended.
The acquisition of Unilab is subject to approval by the... |
| | | 02/10/03 | Quest Diagnostics Launches eMaxx(R) Web Portal, Giving Physicians Access to Lab Tests and Other Clinical Information On-Line| - See eMaxx at Booth #5025 at the HIMSS Conference In San Diego, Feb. 10 - 13, 2003 -
TETERBORO, N.J., Feb 10, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic laboratory testing, information and services, announced today that it
has launched its innovative eMaxx Internet portal to physicians nationwide. The
eMaxx web portal, developed by Quest Diagnostics' MedPlus(TM) subsidiary,
enables doctors to order... |
| | | 02/06/03 | Top Ranking by KLAS Enterprises for Electronic Patient Record Solution Awarded to Quest Diagnostics' MedPlus(TM) Subsidiary|
TETERBORO, N.J., Feb 6, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, announced today that its MedPlus
subsidiary was recognized for the second consecutive year as the number one
document management and imaging (DMI) vendor for its ChartMaxx(R)
enterprise-wide electronic patient record (EPR) solution in a study released by
KLAS Enterprises. MedPlus develops state-of-the-... |
| | | 02/06/03 | Quest Diagnostics Incorporated Commences Cash Tender Offer for Unilab Corporation 12-3/4% Senior Subordinated Notes Due 2009|
TETERBORO, N.J., Feb 6, 2003 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX) announced today that it has commenced a
cash tender offer for any and all outstanding $100.8 million principal amount of
Unilab Corporation 12-3/4% Senior Subordinated Notes due 2009. The tender offer
is in connection with Quest Diagnostics' previously announced agreement to
acquire Unilab Corporation (Nasdaq: ULAB). The tender offer will be financed
with a combination of cash on ... |
| | | 02/04/03 | |
|
|
